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Abstract 
 
Due to the wide spread use of pharmaceuticals in both human and animal populations, the 
contamination of surface waters resulting from the outflow of waste water treatment facilities is of 
growing concern. Conventional methods used for the determination of these compounds often 
require extensive sample preparation in order to achieve appropriate limits of detection and 
quantitation. As a result, analytical methods which utilize these procedures are limited in their 
throughput capacity, while also generating large volumes of solvent waste. Coated blade spray 
(CBS) is a solid phase microextraction (SPME) technique which enables the direct to mass 
spectrometry analysis of extracted compounds with the application of limited organic solvent in 
order to desorb analyte and perform electrospray ionization. Demonstrated herein is the application 
of CBS for the concomitant MS/MS analysis of 12 pharmaceuticals in environmental waters which 
was able to demonstrate LODs for all compounds at concentrations of less than 50 ng/L while 
employing a 30 second analysis time. As select pharmaceuticals are susceptible to 
bioaccumulation, the analysis of fish tissue as a marker of environmental pollution is also an area 
of interest. For this reason a device was developed, the SPME needle, which is able to perform 
rapid tissue analysis without the need for a protective sheathing needle or house, simplifying the 
sampling process. The device was further validated to be reproducible and not effected by puncture 
through protective tissue. Finally, the device was incorporated into a projectile which was 
validated to enable rapid one handed SPME sampler administration in a matter of seconds in an 
on-site proof of concept. 
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1. Chapter #1: Introduction 
 
1.1 Pharmaceuticals in environmental water 
 
The concentrations of pharmaceuticals in environmental waters is an issue of growing 
concern. As one would expect, the environmental concentration of pharmaceuticals in surface 
waters is highly, with these compounds being reported all over the world.1–4 For example 
carbamazepine, a drug used to treat bipolar disorder and epilepsy, has been found at concentrations 
ranging from 0.2 ng/L to 0.75 µg/L in the Grand River (Ontario, Canada).5,6 Due to the multiple 
classes of prescription and non-prescription pharmaceuticals currently used, the long-term 
environmental repercussions of the release of such compounds into the environment are not yet 
fully understood. It has however been observed that at trace concentrations of select 
pharmaceuticals mixture effects can amplify the biological response exhibited by non-target 
organisms.7 In addition, the presence of a target pharmaceutical in a sample can hint at a much 
more complicated underlying picture as drug metabolites and/or transformation products may also 
be present.8 As a result, analysis procedures which monitor particular pharmaceuticals along with 
their major metabolites are beginning to be reported and should become more prevalent as time 
progresses.9,10 
The predominant route of entry for pharmaceuticals into the environment are waste water 
treatment facilities (WWTFs). By definition these sites collect the waste generated from population 
centers into one location to be treated and subsequently released into the environment. Common 
wastewater treatment methods include activated sludge, fixed film, and lagoon-based methods.11 
These methods are typically designed to decompose organic matter via aerobic processes and due 
to the wide range of physical and chemical properties demonstrated by pharmaceuticals, these 
methods are often unable to fully remove such compounds.11 Coupled with geographically variable 
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pharmaceutical prescription patterns, WWTF influent composition, and therefore overall removal 
efficiencies and effluent composition, are highly variable.12 For example, compounds such as 
ranitidine, naproxen, estrone, and triclosan often have removal efficiencies ranging from a 25-75% 
probability of 75% removal, while compounds such as gemfibrozil, carbamazepine, and 
erythromycin have a less than 25% probability of 75% removal when passing through a WWTF.11 
Considering these implications, the release of potentially damaging organic pollutants into the 
environment via WWTF is of significant concern. Coupled to the fact that more than 1400 WWTFs 
release an estimated 18 billion liters of treated wastewater into the Great Lakes basin every day, 
the potential for extensive environmental contamination is significant.11  
Methodologies for improving WWTFs include membrane bio-reactors, which have shown 
great promise, which accelerate the degradation or retention of pharmaceuticals as they pass 
through WWTFs, due in part to the potential for increased bio-mass and not requiring a settlement 
step.13 Further examples of methodologies currently being researched for their ability to remove 
pharmaceuticals from water include ultra violet/ peroxide (UV/H2O2) advanced oxidation process. 
Rosario-Ortiz et. al. demonstrated that for target pharmaceuticals, the percent removal of 
contaminants for this method ranged between 0 and >99%. However, for the vast majority of tests 
performed, irrespective of the UV/H2O2 conditions used, removal percentages of less than 50% 
were observed.14 Similarly, Kimura et. al. reported that ionizing radiation in the form of Cobalt-
60 (60Co) gamma-rays was effective for the removal of select pharmaceuticals from spiked water 
samples.15 However, this study was conducted at concentrations well above those seen in 
environmental samples, and a decrease of efficiency for the removal of pharmaceuticals was 
observed as concentrations were reduced. In other work, Xiao et. al. demonstrated that sonication 
of wastewater effluent was able to degrade select pharmaceuticals,16 although hydrophobic and 
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hydrophilic pharmaceuticals were reported to undergo differing rates of decomposition. Also, 
when real wastewater was considered, due to the presence of organic matter, a significant reduction 
in process efficiency was observed. As a result, it is imperative that advancements in 
methodologies for the analysis of trace organic pollutants, such as pharmaceuticals, be made in 
order to facilitate comprehensive water quality monitoring and screening programs. When on-site 
sampling and sample analysis applications are considered, the requirement of conventional 
analysis methods to employ extensive sample preparation followed by chromatography limits 
throughput. 
As with other anthropogenic compounds in the environment such as pesticides, 
bioaccumulation of pharmaceuticals is a critical parameter when assessing the overall impact of 
environmental pollution due to potentially toxic effects.17–21 As a result, fish living in contaminated 
environments may play a critical role in the identification of the most adverse effects associated 
with exposure to pharmaceuticals as environmental pollutants. In a study conducted by Howard 
et. al., 275 pharmaceuticals which were detected in the environment were considered for their 
potential persistence and chance of bioaccumulation. Of this set, 92 were considered to be 
potentially bioaccumulative, while 121 were considered to be persistent.22 For this reason, 
targeting fish tissue may prove advantageous while performing environmental impact studies 
aimed at detecting pharmaceuticals in environmental surface waters, as they may be in effect pre-
concentrating the pollutants of interest. The issue being, as with conventional water analysis 
procedures, tissue analysis is a very time consuming and tedious procedure requiring extensive 
sample preparation. 
 Solid phase microextraction (SPME), since its invention in the early 90’s, has long been 
applied to the analysis of both simple and complex sample matrices as it combines the sampling 
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and sample preparative steps.23 Certainly when compared to conventional analysis procedures, 
such as those applied for water analysis like liquid-liquid extraction (LLE) and solid phase 
extraction (SPE), SPME offers a more rapid alternative. Furthermore, SPME limits the amount of 
organic solvents used thereby decreasing the environmental impact of the methodologies which 
employ it. In addition to the obvious benefits in terms of sample throughput, SPME has additional 
advantages while performing tissue analysis. Compared to conventional methodologies where 
large portions of tissue must be removed by biopsy needle, or the sample specimen sacrificed, 
SPME offers a non-lethal and minimally invasive alternative.24 
 Solid phase microextraction operates based on a diffusion boundary layer through which 
small molecules migrate forming a concentration gradient as they sorb onto the extraction phase. 
This process is depicted in Figure 1.1, and describes the underlying principle of most SPME 
extraction techniques.23  
 
Figure 1.1: Process of SPME extraction for a liquid sorbent coating by a diffusion boundary 
layer which is controlled by the agitative conditions of the sample25 
𝐶𝑓
′ = Sorbent concentration of analyte at interface with support 
𝐶𝑓 = Sorbent concentration of analyte at interface with sample 
𝐷𝑓 = diffusion coefficient of analyte in liquid coating 
𝐶𝑠′ = Sample concentration of analyte at interface with sorbent 
𝐶𝑠 = Sample concentration in bulk solution 
𝐷𝑠 = diffusion coefficient of analyte in sample matrix 
𝛿𝑓 = sorbent thickness 
𝛿𝑠 = diffusion boundary layer thickness 
K = partition coefficient of analyte for a sorbent 
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Of course, as the sample matrix changes so too does the diffusion and migratory characteristics of 
an analyte, though with the proper calibration techniques these can be accounted for. In addition, 
one of the major strengths of SPME as an extractive technology is that due to it being an affinity 
based extraction procedure, it demonstrates balanced coverage of analytes present in a sample 
matrix. What this means is that, for instance, a compound which demonstrates a high affinity for 
the sample matrix, say water, will tend to be at elevated concentrations over compounds which do 
not demonstrate this degree of affinity or solubility. As a result, if an exhaustive extraction 
procedure is employed, the resultant chromatograms will be dominated by these high affinity 
compounds. With SPME however, these high affinity compounds will demonstrate a lessened 
affinity for the sorbent coating while the low affinity compounds will demonstrate a larger affinity 
for the extraction phase. In this way, the amount of analyte extracted is balanced by its physio-
chemical properties and not by the absolute amount present in a sample.23,26 This characteristic has 
obvious advantages for the analysis of complex sample matrices such as environmental waters and 
fish tissue. As a result, the SPME technology was chosen as the extraction and sample preparation 
methodology to be employed in this work.  
 
1.2 Rapid analysis: Direct to mass spectrometry 
 
While the application of SPME to the analysis of pharmaceuticals and other anthropogenic 
compounds in environmental waters is well documented in the literature,6,26–31 method throughput 
has to date been limited by the use of chromatography,  thus causing the separation portion of the 
analytical method (i.e. GC or LC) to be a time-consuming endeavor. One potential avenue of 
improvement is that of the merger of SPME and direct to mass spectrometry (MS) technologies. 
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If successful, the analysis of trace environmental contaminants will provide a cheaper, faster, and 
more environmentally friendly alternative to conventional analytical techniques. 
Although the direct-to-MS analysis of organic compounds is still in its infancy,32 a wide 
range of methods are currently being researched due to the potential of the field.33 Though not a 
comprehensive list, some examples are direct analysis in real-time (DART),34 paper spray (PS),35 
laser ablation electrospray ionization (LAESI),36 and desorption electrospray ionization (DESI).37 
All of these methods (and the many not mentioned here) share the same underlying purpose: to 
generate ionic species under ambient conditions to be introduced into a mass spectrometer for 
detection/identification.38  
Paper spray was first developed and introduced by Wang et. al.39 In the presented 
application, a piece of paper is placed in a specially designed mount, which allows for the 
application of a voltage onto the paper. Once in place, an aqueous sample is applied to the paper 
and left to dry. A desorption solution is then introduced to the paper, dissolving the analyte, and a 
potential difference is applied between the paper and MS inlet, initiating electrospray ionization, 
resulting in the formation of charged micro droplets of solvent that contain analyte. As the droplets 
evaporate, the charge is ultimately transferred to the analyte.39 Notably, the use of a piece of paper 
with a pointed tip was found to enable the formation of a Taylor Cone, which facilitates ionization 
and allows for the aiming of the charged species toward the inlet of the MS.35,39 Paper spray has 
been applied in a variety of applications; some examples include the analysis of blood for 
pharmaceuticals, and the identification of dyes in foodstuffs.40–43 
Due to the nature of PS, pre-concentration of analyte onto the paper substrate is often 
difficult limiting the application of this method for trace organic analyses, like that required in 
environmental applications. Similarly, if direct sample analysis is considered, the presence of 
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matrix effects associated with un-processed samples often results in ion suppression and decreased 
method response. In order to eliminate both of these shortcomings, the coupling of pre-
concentration techniques to direct to MS analysis has gained increasing attention. One such 
example is the work performed by Zhang et. al. and Zheng et. al., where micro-SPE was 
successfully coupled to PS for the analysis of pharmaceuticals in blood, as well as dye components 
in chili products.44,45 Other applications involving pre-concentration of analyte prior to direct to 
MS analysis include the work performed by Rosting et. al. and Zhang et. al. in the application of 
thin-film membranes; while Rosting et. al. demonstrated that a liquid membrane could be used as 
an extraction phase to pre-concentrate analyte prior to DESI, Zhang, et. al. showed that the 
application of a complex solution to the surface of a permeable membrane would result in the 
isolation of analytes unable to permeate the membrane on the surface 46,47 
Among these advancements, there have been a range of applications which aim to directly 
couple the SPME technology directly to MS. Some of these applications include in-line direct 
infusion of SPME fiber desorption solutions,48 conventional SPME blades used for DESI,49 coated 
mesh direct analysis in real time (DART),50 bio-SPME fiber nano-ESI,51 coated blade spray 
(CBS),52 and more recently applications with the open port probe (OPP),53 and dielectric barrier 
discharge ionization SPME.54 Of these applications CBS was chosen as the methodology to be 
implemented in this work for the targeted analysis of pharmaceuticals in environmental water, as 
it provides the most rapid analysis procedure. In addition and the method of ionization, ESI, is 
well suited to the class of target compounds and the functionalities they typically possess. Images 
of the CBS ionization process are provided in Figure 1.2. The main difference between PS and 
CBS is that the blade used to produce the charged species is utilized as the sampling/sample 
preparation device (i.e. matrix clean-up and analyte enrichment can be achieved simultaneously). 
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MS inlet 
Coated blade 
CBS is performed by exposing a metal blade whose tip has been coated with a sorbent to a sample 
matrix. The analyte will then partition onto the sorbent, extracting it and concentrating the analyte 
onto the coated blade. The blade is then removed from the sample matrix, followed by application 
of an appropriate desorption solution to the blade to desorb the analytes from the sorbent on the 
blade. Once a sufficient period of time has elapsed to desorb the analyte, while limiting the loss of 
solvent to evaporation, the blade is placed in front of the MS inlet and a voltage is applied, resulting 
in analyte ionization and analysis. 
 
 
 
 
 
Figure 1.2: Schematic of the CBS ESI process 
 
CBS has one main underlying benefit, in that the same piece of equipment used in 
ionization is also used as the sampler, greatly simplifying the methodology. In addition, as it 
operates using SPME principles it is able to extract analytes from the sample matrix and enrich 
samples prior to analysis. This extractive and concentrative property of SPME is ideally suited to 
direct to MS analysis techniques, as it provides a clean, concentrated extract from the sample, 
thereby limiting matrix effects which could decrease response. 
The direct-to-MS analysis of environmental samples for pharmaceuticals is an emerging 
field of research. Boisvert et. al. have been able to demonstrate its feasibility, where the analysis 
of pharmaceuticals in wastewater was directly coupled to MS with the use of laser diode thermal 
Analyte 
Charged solvent 
droplet 
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desorption.55 Here, a sample is placed and dried onto a patented LazWell™ plate, where it is 
thermally desorbed via laser interrogation and carried through a coronal discharge by a constant 
flow of gas, resulting in analyte ionization followed by introduction into a MS. The devised method 
requires extensive sample preparation by filtration, solid phase extraction, elution, and subsequent 
pre-concentration of sample matrix prior to analyte ionization and analysis. However, the 
researchers were able to achieve limits of detection for a variety of pesticides and pharmaceuticals 
in the 28-162 ng/L range. Similarly, DESI has been used for the screening of cosmetic products 
from environmental samples.56 In this application, tap water was analyzed through the direct use 
of thermally assisted ionization, where the sample target was heated during desorption electrospray 
ionization. Limits of detection in the ng/L range were achieved, though the range in which the 
analytes detected could be quantified was in the µg/L range.  
 
1.3 Fish tissue analysis: SPME 
 
 The implementation of SPME for the analysis of fish tissue, as with any biological sample 
matrix, is certainly advantageous due to the minimally invasive and non-lethal ability to perform 
these samplings. For this reason SPME has been documented and used to great effect for the 
analysis of fish tissue for target compounds of interest.57–60 However, broadly speaking traditional 
SPME fibers are quite fragile due to the fused silica core used as a support to bind the extractive 
coating.61 Alternatives which are often employed for in-vivo applications include titanium, or 
nickel-titanium alloy (nitinol) supported SPME coatings. In addition, the chemical immobilization 
of a coating onto such a support has also been shown to be fairly robust.62–64 However, such devices 
are quite flexible due to the small diameter of the supporting material; an intrinsic property of 
many SPME devices which may not be desirable for applications requiring the puncture of a robust 
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sample matrix. These limitations, namely fragility and flexibility, result in SPME fibers being 
augmented with sheathing needles in order to support and/or puncture sample matrices such as fish 
scales for in-vivo applications (Figure 1.3).57,59,60  
 
 
Figure 1.3: SPME fiber introduction device used to puncture fish scales65  
 
As such, these characteristics could be considered a detriment to the streamlined nature of 
SPME as a rapid and easily executed sampling and sample preparative technique as the 
implementation of the SPME technology becomes cumbersome and slow. For this reason it is 
imperative that robust SPME devices which require no additional supporting hardware or 
sheathing needle are developed. A device of this nature would not only facilitate efficient 
sampling, it would highlight the advantageous nature of SPME as a means by which to perform 
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chemical biopsies of tissue, thereby avoiding the invasiveness and complexity of traditional tissue 
sampling procedures, such as physical tissue biopsy.24 
1.4 Summary 
 To conclude, the technology of SPME has been shown to be highly applicable to the 
analysis of environmental matrices for anthropogenic compounds, whether they be surface waters 
or the tissue of species which are susceptible to bioaccumulation. These traditional SPME 
methodologies have multiple advantages over conventional analysis methodologies due in part to 
the rapid sample preparative nature of SPME and its ability to provide a clean extract and balanced 
coverage. However, limitations to the SPME technology do exist. As a result, the thesis herein 
aims to address two of these limitation: 1) by applying SPME CBS for the rapid screening of target 
pharmaceuticals at their source, WWTF, and 2) by developing a more robust SPME device capable 
of performing in-vivo sampling with no protective housing or pre-puncture needle. 
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2. Chapter #2: Development of CBS for targeted environmental 
analysis 
  
2.1 Introduction 
 
Direct to MS techniques afford analysts the ability to perform rapid screening and 
quantitative procedures. Of course, as these procedures do not possess a chromatographic 
separation, isobars or matrix constituents which demonstrate similar select reaction monitoring 
(SRM) transitions cannot be resolved, imposing a limitation on the technique. With this is mind it 
is important to investigate these direct to MS techniques in order to identify such limitations and 
identify compounds which may not be suitable for this method of analysis. Technologies such as 
ion-mobility, or additional ion fragmentation procedures (MSn) could be implemented in order to 
further resolve compounds which may not be suitable for direct to MS/MS analysis. Of course, 
these limitations must be identified and understood in order to take full advantage of additional 
mass spectrometric resolution procedures. The work to be discussed here encompasses some 
method development procedures for the application of the direct to MS analysis technique of CBS, 
for the targeted analysis of pharmaceuticals in environmental waters. Conducted experiments 
include an investigation of the desorption/ionization solution composition used in CBS 
applications, as well as the relation of sample volume and sample matrix pH towards method 
response.  
When assembling a group of pharmaceuticals to be targeted, care was taken to select 
analytes which were of varied classes in terms of what they were prescribed to treat, so as to obtain 
a broad range of both structural and logP variations. The importance of a wide range of logP values 
for the target compounds cannot be understated, as the devised method may be selective for certain 
Introducti n 
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compounds, and consequently, extra optimization steps may be required for highly polar analytes 
due to their high affinity for aqueous media relative to the sorption phase used in SPME. The target 
compounds to be used for method development are listed in Table 2.1. 
 
Table 2.1: Target pharmaceuticals and their physical chemical properties 
Name Structure Use 
MW 
g/mol 
pKa log P 
Ionization 
mode 
(adduct) 
Sertraline 
 
 
 
Selective serotonin 
reuptake inhibitor  
class 
305.074 9.9 5.1 (H) + 
Methadone 
 
 
 
Synthetic opioid 309.45 8.9 4.2 (H) + 
Fluoxetine 
 
 
 
Selective serotonin 
reuptake inhibitor  
class 
309.326 9.8 4.09 (H) + 
Paroxetine 
 
 
 
Selective serotonin 
reuptake inhibitor  
class 
329.365 9.8 3.89 (H) + 
Monensin 
 
 
 
Ionophore, Na+/H+ 
antiporter 
670.871 4.3 3.72 (Na) + 
Propranolol 
 
β-blocker 259.34 9.4 3.1 (H) + 
Diazepam 
 
 
 
Benzodiazepine 284.7 3.4 2.91 (H) + 
Erythromycin 
 
 
 
Macrolide 733.9 8.9 2.83 (H) + 
Carbamazepine 
 
 
 
Antiepileptics 236.27 15.9 2.67 (H) + 
Ranitidine 
 
Antihistamine, treats 
ulcers 
314.403 8.1 1.23 (H) + 
Codeine 
 
Opiate used to treat 
pain 
299.364 8.2 1.2 (H) + 
Salbutamol 
 
Inhaler for asthma 239.311 10.3 0.01 (H) + 
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2.2  Experimental 
2.2.1 Materials and reagents 
The pharmaceuticals propranolol, prorpanolol-d7, sertraline, sertraline-d3, fluoxetine, 
fluoxetine-d7, paroxetine, paroxetine-d6, methadone, methadone-d3, codeine, codeine-d3, 
diazepam, and diazepam-d5 were purchased from Cerilliant of Sigma-Aldrich (Roung Rock, TX, 
USA) while salbutamol, monensin, erythromycin, ranitidine and carbamazepine were purchased 
from Sigma-Aldrich (Oakville, ON, Canada) and erythromycin-d3, ranitidine-d6 were purchased 
from TRC (Toronto Research Chemical, Toronto, ON). For chromatographic separations and 
standard preparation, the MS grade methanol, acetonitrile and water were obtained from Fisher 
Scientific while the salts formic acid (FA) and ammonium acetate (AA) were purchased from 
Sigma Aldrich (Oakville, ON, Canada). Plastic 300 µL vials and amber 2mL and 10mL glass vials 
along with pre-pierced PTFE/Silicon septa used were purchased from Canadian Life Sciences 
(Peterborough, ON, Canada). Hydrophilic lipophilic balanced (HLB) particles used were obtained 
from Waters (Wilmslow, UK) while the C18 particles used were obtained from Supelco 
(Bellefonte, USA). 
 
2.2.2 Manufacture of CBS devices 
 
Coated blade spray devices were made of stainless steel sheets which were 5 cm in length 
and 0.5 cm in width, which were brought to a tip. These blades were then placed in 37 wt% 
hydrochloric acid and sonicated at room temperature in order to roughen the metal surface 
facilitating adhesion of the sorbent coating. Etching was performed for 20 minutes, during this 
time the blades were shook every 5 minutes so as to ensure any overlapping regions of the blades 
were uncovered and etching was homogeneous. Etched blades were then removed from the acid, 
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rinsed in water using sonication 3 times for 5 minutes, followed by a quick rinse in methanol and 
dried at 80 °C for 5 minutes. HLB-PAN or C18-PAN extractive coatings of thickness 10 µm and 
length 1.5 cm were then applied using a proprietary coating procedure.  
 
2.2.3 Instrumental analysis 
 For CBS experimentation a modified TSQ Quantiva (Thermo Scientific, San Jose, USA) 
was used. In place of the traditional ESI source used for LC-MS/MS, a custom ionization source 
constructed by the University of Waterloo Science Shop was employed, and is shown in Figure 
2.1. This source allows for the controlled placement of CBS devices in front of the MS inlet so as 
to ensure the distance between the CBS device tip and the transfer tube is reproducible from one 
device to the next. In order to initiate the ESI process from the tip of the CBS devices a potential 
difference of +4 kV was used. 
 
 
 
  
 
 
 
 
Figure 2.1: Custom CBS ionization source manufactured for the TSQ-Quantiva 
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 As there are 22 target species to be monitored in this particular study, a 30 second spray 
event with a 50 ms dwell time per SRM transition was used so as to provide an adequate number 
of scans per transition. With this in mind, if a smaller number of targets were of interest much 
shorter ionization events could be applied allowing even faster analysis times.66 Specifics relating 
to the MS/MS parameters as well as the SRM transitions monitored are available in Appendix #1. 
In all CBS experiments, unless otherwise specified, experiments were conducted in triplicate and 
the desorption/ionization solution was applied to the surface of the coated blades for a duration of 
20 seconds in order to desorb extracted analyte prior to the initiation of ESI. 
 
2.3 Results, discussion, and experimental specifics 
 
2.3.1 Coating comparison, C18 v.s. HLB for the target compounds 
 
 In the discussed work HLB extractive coatings were utilized as the sorbent phase for the 
conducted experiments. HLB particles were observed to provide a much larger response for the 
target analytes, in particular carbamazepine, codeine, salbutamol and ranitidine (Figure 2.2) 
following a 2 minute extraction form a 1 µg/L solution in water. Though monensin did in fact 
demonstrate greater method response when a C18 extraction phase was implemented, the coverage 
of analytes extracted by HLB provided the best overall response. Of course, if monensin was the 
sole target of any particular application a C18 coating would be advantageous. 
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Figure 2.2: Coating comparison, HLB v.s. C18, of % response obtained for target pharaceuticals 
in water 
 
2.3.2 Effect of desorption and ionization solution composition 
 
  As with any electrospray ionization process, the stability of the spray itself from the tip of 
the coated blade is a critical parameter when performing quantitative analysis. A stable 
electrospray will ensure a reproducible introduction of analyte into the mass spectrometer and 
hence inter blade reproducibility. As CBS uses a non-continuous flow of organic solvent to 
perform ESI there is depletion of the organic desorption/ionization solvent due to the electrospray 
process itself, but also loss due to evaporation. In order to assess the spray stability produced by 
CBS devices, varied desorption solvents were applied and the response of extracted analytes were 
monitored for 30 seconds. The base of all desorption/ ionization solutions tested was that of 
methanol, due to its extensive use as the desorption solution for HLB sorbents in the literature. 
Additives included acetonitrile and water, while the formic acid concentration was held constant 
at 0.1 volume percent (v%).  
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What was immediately apparent was that when excessively large volumes of desorption 
solution were used (>20 µL) the solution would quickly migrate to the tip of the device upon the 
application of the spray voltage, and would actually splash the MS inlet, providing irreproducible 
spray events. As a result, 15 µL desorption volumes were used in all further studies. Instrumental 
response relating to four tested compositions are provided in Figure 2.3.  
 
 
 
Figure 2.3: Resultant ESI spray stability for varied CBS desorption/ionization spray solutions; a) 
methanol, b) 5% water in methanol, c) 5% acetonitrile in methanol, d) 5% of water and 5% 
acetonitrile in methanol 
 
 One important observation made was that when the solution was composed entirely of 
organic solvent, whether it be 100% methanol, or 95% methanol and 5% acetonitrile, the solution 
would be exhausted before a full 30 seconds of ESI. What appeared to alleviate this was the 
presence of water in solution, as both compositions which incorporated water demonstrated 
extended ESI times. Though only one trace of each solvent composition is shown, the methanolic 
solution with 5% water was identified as the most reproducible, and was therefore used in all future 
applications. 
Once a methanolic/water solution was identified as providing sufficient spray stability, 
methods of further improving response were investigated. The primarily focus being on the effect 
of additives to the desorption/electrospray ionization solution. It has been documented that the 
presence of ammonium in methanolic mobile phases used for LC-ESI/MS analysis often improved 
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the response of proton adducts in positive ionization mode. The hypothesis behind this observation 
being that, though in the aqueous phase there may be a larger degree of ammonium adducts, proton 
transfer in the gas phase from ammonium to the analyte would improve the magnitude of proton 
adducts observed.67 The ammonium salt used for this purpose in the literature has typically been 
ammonium formate or ammonium acetate. As ammonium acetate was available at the time of 
experimentation, it was used in this study. Investigations employed 4 ammonium acetate 
concentrations, 0 mM, 6 mM, 12 mM and 24 mM in the presence of a 95:5 methanol water solution 
with 0.1v% formic acid. Extractions were performed for 10 minutes at 1200 rpm from a 1 µg/L 
aqueous solution of volume 1.5 mL.  
From this study it was evident that the presence of ammonium acetate did in fact improve 
the magnitude of observed proton adducts for all compounds which demonstrated one, with there 
being no significant difference between the response of 12 mM and 24 mM solutions. For this 
reason, further experimentation utilized a 12 mM concentration of ammonium acetate. 
Furthermore, the concentration of formic acid was investigated at this ammonium acetate 
concentration by repeating the experiment as outlined above, however in this instance the 
ammonium acetate concentration was held constant at 12 mM, while the formic acid concentration 
was tested at 0 v%, 0.1 v% and 0.5 v%. The results of this study are presented in Figure 2.4 where 
it is clear that the optimum value of formic acid is that of 0.1 v% while employing a 12mM 
ammonium acetate concentration. 
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Figure 2.4: Optimization of ammonium acetate and formic acid concentratins in the CBS desorption/ 
ionization solution 
 
Of course with the presence of ammonium now in the solution there would be ammonium 
adducts of the target compounds entering the mass spectrometer. To determine whether or not 
these adducts were of a significant and relevant magnitude compared to the proton adducts, the 
analytes were formulated at 1 ppm in a 95:5 methanol/water, 12mM AA, 0.1 v% FA. This solution 
was then analyzed by direct infusion using the commercial TSQ-Quantiva ESI source operated at 
room temperature. Of all the compounds, the only one to demonstrate an appreciable magnitude 
of ammonium adduct was that of propranolol. Once identified, the ammonium adduct of 
propranolol was tuned on the instrument and targeted while performing CBS ESI and compared 
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to the magnitude of the protonated adduct obtained in the same experiment. It was concluded that 
the proton adduct was still the most significant (2 times greater) of the two adducts observed, and 
as such was used as the target parent ion in subsequent analysis. 
 
2.3.3 Sensitivity and sample volume  
 
 When performing SPME based extractions one is typically restricted in the volume of 
sample matrix which can be analyzed, as is the case in bio-fluid analysis. However, as 
environmental sample matrices are of near endless volume this is not a limitation which is imposed 
on environmental applications of SPME technologies. With this is mind, it is still important to 
provide a methodology which limits the volume of sample required so as to prevent extensive or 
difficult sample handling or transportation. Small volume sample analysis is, of course, 
advantageous when one considers the high-throughput capability of SPME as a sampling and 
sample preparative technique. As a result SPME can provide a unique opportunity to its users, 
allowing the entire analytical workflow to be automated, from sampling to instrumental analysis. 
For this reason sample volumes used for SPME extractions of environmental matrices should still 
be kept to a minimum while maintaining an appropriate method sensitivity.  
 Upon the initiation of the project the experimental sample volume used was that of 1.5 mL 
as this could allow the easy coupling of the methodology to an already existing 96-well plate 
system enabling high-throughput analysis. To assess the preliminary limit of detection (LOD) and 
limit of quantitation (LOQ) of a method employing this sample volume, real river water was 
analyzed. This sample was verified to be blank by external calibration and was spiked at 5, 10, 20, 
50 and 100 ng/L and 0.5, 1, 5 and 20 µg/L, with available internal standards spiked at 3 µg/L. HLB 
coated blades were placed in the sample solution and agitated using vortex for 2 minutes. Blades 
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were then subsequently washed in 1.5mL of MS grade water prior to being left to dry for 5 minutes. 
For this application a standard CBS desorption solution of methanol with 0.1v% of formic acid 
was used is this study was conducted prior to the desorption solution optimization. Each calibration 
point was tested using two blades, using each side of the blade to perform instrumental analysis 
giving n=4 replicates at each calibration point. In order to correct for variation in the electrospray 
process and so as to calibrate total analyte concentration, response was calculated using response 
of analyte divided by internal standard response of that same analyte. For the analytes salbutamol 
and monensin, internal standards were not available so response was simply used on the y-axis as 
correction with the internal standard of other analytes did not improve relative standard deviation 
(RSDs). 
 In general, method performance was good, correlation coefficients (r2) were observed to 
be >0.9920 for all compounds over the calibration range of 100 ng/L to 20 µg/L. However, 
correlation coefficients in the range 5 to 100  ng/L were much worse, with compounds having an 
average r2 of 0.8100 with only six compounds (carbamazepine, propranolol, ranitidine, codeine, 
fluoxetine and erythromycin) demonstrating an r2>0.9800. Of these compounds, only four were 
able to achieve the desired LOD (3x blank value, calibrated)68 of less than 50  ng/L. These 
compounds were, propranolol (28 ng/L), ranitidine (23 ng/L), fluoxetine (22 ng/L) and 
erythromycin (5 ng/L). With this it was identifiable that the CBS technology could certainly meet 
the project goals with further development. In addition, it was clear that at elevated concentrations 
(>1 µg/L) analyte response was linear and did not pose any real significant challenge in terms of 
quantitative analysis so the focus was solely on improving linearity in the sub  µg/L range, namely 
1-1000 ng/L, where the target compounds would be expected in real world samples. 
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 When dealing with SPME extractive procedures, the most accessible parameters by which 
to improve sensitivity are that of sampling time and sample volume. As mentioned, environmental 
sample matrices are of near endless sample volume and as a result its effect is worth investigating. 
In addition, extraction time was increased from 2 to 10 minutes so as to improve method response. 
Extraction time profiles were able to identify that at a 1.5 mL sample volume at 100 ng/L using a 
1.5 cm HLB coated blade, the extractions reached an apparent equilibrium at ~4 minutes for all 
compounds. However, due to the strong sorbent nature of HLB for the target compounds this may 
actually be the observation of an exhaustive extraction. This hypothesis was indeed confirmed 
when extraction time profiles were conducted for the target analytes in 9 mL of sample at 100 ng/L 
using 1200 rpm, where linear uptake of analyte was observed well past 4 minutes of extraction. 
As a rapid screening technique was the goal of this project, extraction times of greater than 10 
minutes were not investigated. The magnitude of response increase corresponding to an increase 
in sample volume size at 100 ng/L using a 10 minute extraction at 1200 rpm is apparent in Figure 
2.5 where codeine, erythromycin and paroxetine are displayed.  
 
Figure 2.5: Effect of sample volume on overall method sensitivity for the target compounds 
codeine, erythromycin and paroxetine 
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As is evident, method response was the greatest when a sample volume of 9 mL was 
employed, though for some compounds (salbutamol, diazepam, sertraline, methadone, paroxetine 
and monensin) there was not a significant difference between the response generated between the 
4 mL and 9 mL sample sizes. Due to this, the 9 mL sample size was employed in subsequent 
experiments so as to maximize response for all compounds, though a lower sample size could have 
been used if only the compounds listed above were of interest. 
 
2.3.4 Effect of sample matrix pH on method sensitivity 
 
 When dealing with sample matrices which are as variable as environmental ones, it is 
important to understand how these variations may affect the sensitivity of a method employed. 
One such variable is that of sample pH. When considering conventional sample extraction 
procedures, or more broadly speaking, exhaustive extraction procedures, pH can be a critical 
parameter so as to limit the occurrence of breakthrough of a sorbent bed. By ensuring that the 
analyte is predominantly in its non-ionic state, the species will bind more readily to the sorbent. 
Of course this becomes a bit more complicated when dealing with non-exhaustive sampling 
procedures as the factors at play encompass not only the neutral fraction of analyte, but the affinity 
of the compound for the extraction phase and the effect of extraction on the equilibrium between 
protonated and neutral analyte species in solution. For these reasons the modification of pH and 
its effect on method response was an important area of investigation so as to identify if a significant 
boost in sensitivity was achievable by the implementation of a pH standardization procedure.  
In order to assess this parameter, calibration plots were formulated in blank river water at 
pH’s of 6, 7, 8, 9 and 10 over a concentration range of 100 ng/L to 2 µg/L. This particular pH 
range was selected as slightly basic conditions have been identified to provide the best results 
when extracting pharmaceuticals and related compounds using HLB extraction phases by SPE.5 
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In order to give a graphical representation of the data so as to visualize any trends of response vs. 
pH, the slope of the resultant calibration curves were plotted vs. pH so as to effectively give a 
response per unit concentration value on the y-axis. It is important to note that for this particular 
experiment, the internal standard used to correct for variation in ESI was added after the extraction 
had occurred. Of course, if the internal standard was present in the sample matrix during the time 
of extraction, calibration of the ratio of analyte to internal standard would have given the same 
slope for all pH’s investigated. As the presence of internal standard during extraction would have 
corrected for the variation in amount extracted at each pH. This was accomplished by performing 
typical extraction procedure with one modification. After rinsing, and once the blades were dry, 
10 µL of a 50 µg/L methanol solution containing the analyte internal standards was spotted onto 
the surface of the blade. This droplet was then allowed to dry and instrumental analysis was then 
performed as usual. 
 Interestingly, and unsurprisingly, the resultant trends were more complicated than simply 
being related to pKa of the target analytes. This is evident in Figure 2.6 where the trends of 
response per unit concentration v.s. pH are displayed for fluoxetine (pKa=9.8) and sertraline 
(pKa=9.9).  
 
Figure 2.6: Sensitivity as a function of sample matrix pH for the target compounds fluoxetine 
and sertraline 
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Even though these two compounds demonstrate almost identical pKa’s, they have different 
maxima of sensitivity at varied pH, with fluoxetine demonstrating its greatest response at a pH of 
9, while sertraline demonstrates its greatest sensitivity at a pH of 7. As this analysis was performed 
in real river water, the cause of these trends could be attributed to a combination of factors. For 
instance, the affinity of the target analytes may vary with pH, as would the affinity of the analytes 
for any matrix constituents such as suspended solids or dissolved organic matter. This varied 
interaction with the sample matrix itself would affect the free concentration of analyte and thereby 
alter the extraction. With this in mind, however, the main observation of this study was that pH 
modification did not produce a significant increase in method response for any one analyte. 
Though the majority of compounds did in fact demonstrate a maximum response at a particular 
pH (see Appendix #2), the increase was not significant enough so as to justify an additional sample 
preparation step. As such, an addition to the work flow would reduce the rapid nature of the 
methodology, and limit its throughput capacity as a screening procedure in the real world. 
Additionally, as the target compounds are so varied so too are the pH’s at which each of them 
demonstrate their greatest sensitivity. As a result, for the purposes of this study the modification 
of the sample pH would not provide a global improvement and was therefore not implemented in 
further work. It should, however, be noted that at low pH (i.e., pH < ~6.5) there is a decrease of 
sensitivity in almost all cases. As a result the pH of samples should be measured prior to analysis 
for comprehensiveness, as correction of the pH to a more neutral or slightly basic condition would 
in fact prove advantageous, though only for the cases in which a pH < 6.5 was observed. 
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2.3.5 The relationship between extraction phase thickness and method response 
 
 When dealing with SPME technologies the extraction phase thickness is of critical 
importance as this characteristic of the device will be a determining factor in the overall capacity 
of the sorbent. As an extraction phase is thickened, so too is the capacity of the coating. What is 
important to recognize, however, is that as thickness increases the time required to desorb the 
analyte is also increased as the organic solvent used for this purpose must penetrate the coating. 
For these reasons high affinity coatings of minimal thickness are advantageous for the majority of 
SPME applications, with these characteristics being of critical importance when seeking a rapid 
sampling and rapid analysis methodology. Of course, if traditional desorption of a SPME device 
is employed, where the organic solvent used is then analyzed by liquid injection into either GC or 
LC instrumentation, the desorption step can be modified. This then ensures complete analyte 
desorption and hence better sensitivity when thicker coatings are used.  
In order to investigate the effect of coating thickness on method response when applying a 
direct to mass spectrometry approach, CBS devices were tested which had 1 layer, 3 layers and 5 
layers of an HLB-PAN coating applied; corresponding to coating thicknesses of 10, 30 and 50 µm 
respectively. Each of the coating thicknesses was analyzed in triplicate, having each of the 9 blades 
used loaded with analyte by performing extractions from a 1  µg/L, 9 mL solution at 1200 rpm for 
10 minutes. Analysis was then performed using the 95:5, MeOH/H2O, 12 mM AA, 0.1 v% FA 
desorption solution (15 µL, 20 s desorption). 
 What was immediately apparent was the reduction in instrumental response as thicker 
coatings were used. This observation held true for all target compounds with the exception of 
carbamazepine and diazepam which maintained a constant response, while the response of 
monensin increased with coating thickness. This observation speaks to the relative complexity of 
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SPME extractions when a wide range of compounds are of interest. The hypothesis for the cause 
of this observation, of some compounds demonstrating equal or greater response as coating 
thickness is increased, is that of coating capacity. Simply, as more analyte was extracted, more 
analyte was available to be analyzed. The difficulty comes in explaining why the response dropped 
for the majority of the compounds tested, and the main hypothesis for this observation in the drop 
of instrumental response associated with coating thickness can be visualized in Figure 2.7.  
 
 
 
Figure 2.7: Visual depiction of potential phenomenon leading to reduced response with thicker 
extraction phases 
 
Essentially, as a constant volume of desorption/ ionization solution was applied, the volume of 
solvent available to undergo ESI was less when a thick coating was used. The resultant 
phenomenon would be much like that observed in chromatographic peak broadening resulting 
from slow mass transfer in thick stationary phases. This was caused by a more significant 
proportion of the solvent residing within the coating and therefore it could not easily carry analyte 
to the tip of the CBS device in order to participate in the ESI process. This hypothesis was further 
corroborated by the observation that when a thick coating was used the ESI would stop prematurely 
or be more unstable than the ESI generated from a CBS device utilizing a thinner coating. In 
addition, for the 5 layer CBS devices, a 15 µL desorption volume was not sufficient and a 20 µL 
desorption volume was required in order to have a fully wetted surface of the device after the 20 s 
Thin coating Thick coating 
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desorption time had elapsed. The results of this particular study for the target analytes propranolol, 
codeine, and monensin are given in Figure 2.8. 
 
Figure 2.8: Response of the target compoounds prrapnolol,codeine and monensin as a function 
of extraction phase thickness 
 
 This realization, that a thinner coating in fact provides greater sensitivity than a thicker 
coating for CBS is of great significance. This conclusion essentially identifies the most easily 
produced device, as well as the device which requires the least amount of polymer coating, to be 
the optimal device under the conditions tested. This increases the throughput of device 
manufacture, and reduces consumption of the most costly portion of a CBS device, the extractive 
coating. Single layer HLB-PAN coatings were employed for all further experimentation. 
 
2.4 General observations and summary of findings 
 
 Over the course of the research outlined in this chapter, some general observations were 
made pertaining to the CBS technology. The most significant of which being that the geometry at 
the tip of the device is a critical parameter in ensuring that a stable and unidirectional ESI is 
obtained. In order to accomplish this, after the extractive coating has been applied, a sanding step 
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is required. This sanding step removes any polymer coating from the tip of the device which would 
otherwise interfere with the formation of the Taylor cone during ESI. Additionally, this step 
provides a smooth surface which enables the user to better place the device in front of the MS 
inlet, and acts as a standardization step conducted for all CBS devices in order to ensure each 
sprays equivalently, or at least similarly. This tip geometry will also dictate whether a CBS device 
will spray equivalently from both sides.  
 Upon the completion of the method investigation steps, a procedure which is well suited 
for the rapid screening of environmental water or WWTF effluent streams for target 
pharmaceuticals was identified. It consisted of performing an extraction from 9 mL of sample 
using a 10 minute extraction time at 1200 rpm. After extraction the CBS device is rinsed with MS 
grade water in order to remove any attached macromolecules or matrix constituents and allowed 
to dry prior to instrumental analysis. Once positioned 1cm from the MS inlet, a 15 µL droplet of 
the desorption/ ionization solution (95:5, methanol/water, 12mM AA, 0.1 v% FA) was placed on 
the coating and left to rest for 20 seconds. After this desorption time had elapsed, a +4 kV potential 
difference was applied for 30 seconds initiating ESI and MS/MS separation and detection. Of the 
parameters investigated and not taken into consideration in this final method is that of the sample 
matrix pH. As the modification of sample pH was identified to not significantly affect the overall 
method sensitivity this time consuming sample preparation step was not performed so as to 
facilitate the rapid screening of real world samples. Additionally, as the calibration is performed 
by ratio of analyte signal to spiked internal standard signal, the pH will not effect the calibrated 
value. In order to demonstrate the ability of the method to perform as required, a real river water 
sample was obtained using a 1 L amber glass bottle and stabilized with 0.2 g/L of sodium azide 
and 0.05 g/L of ascorbic acid. The sample had a pH of 7.7 and which was verified to be blank by 
31 
 
the use of external calibration, characterization such as total organic carbon determination and 
sample conductivity were not performed as this was a proof of concept. This sample was then 
spiked with the target analytes over the concentration range of 1 to 1000 ng/L and LOD and LOQ 
values were calculated. Resultant LOD and LOQ values for the spiked river water, as well as LOQ 
values for a calibration curve generated in MS grade water are provided in Table 2.2. 
 
Table 2.2: Resultant LOD and LOQ values for the CBS methodology in real river water to be 
applied in the WWTF effluent screening study 
 Compound 
MS Water River water 
LOQ 
(ng/L) 
LOQ 
(ng/L) 
LOD 
(ng/L) 
Ranitidine 1 32 7 
Codeine 7 116 24 
Salbutamol 4 36 8 
Carbamazepine 4 35 9 
Diazepam 13 128 32 
Propranolol 6 16 4 
Erythromycin 1 4 1 
Paroxetine 3 64 16 
Methadone 2 8 2 
Fluoxetine 19 163 39 
Sertraline 79 188 44 
Monensin 35 98 22 
 
 
As shown, in a real river water sample the LOD for all target compounds was below a value of 50 
ng/L, having only 4 compounds, codeine, diazepam, fluoxetine and sertraline demonstrate a LOQ 
larger than 100 ng/L. With this, it can be concluded that the method used is capable of performing 
the rapid screening of real world samples for target pharmaceuticals in the low ng/L range. 
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3. Chapter #3: Targeted analysis of pharmaceuticals in WWTF final 
effluent 
 
3.1 Introduction 
 
 Waste water treatment facilities offer environmental agencies an interesting opportunity 
when gauging the magnitude of environmental pollution and its sources. Unlike other 
anthropogenic compounds such as pesticides, which enter the aquatic environment by means of 
leaching from contaminated soils during rain events or irrigation, the sources of pharmaceuticals 
are much more concentrated. By definition, WWTF concentrate the waste water generated over a 
relatively large area and release the treated effluent at a single location, effectively forming a point 
source of environmental pollution.  
Currently, all accredited methods employed for the analysis of pharmaceuticals are very 
similar in methodology and highly dependent on the sample matrix. These methods typically rely 
on filtration and subsequent SPE, or LLE to concentrate the target analytes. These concentrated 
samples then undergo chromatographic separations, either GC or LC, in order to isolate each target 
analyte from other sample matrix constituents.69,70 In essence, the accredited methods are time-
consuming and environmentally taxing due to the extensive sample preparation often required, 
long chromatographic analyses, and the use of organic solvent. As a result, these methods cannot 
be used for rapid screening and quantitation of pharmaceuticals in environmental samples due to 
the slow turn-around time between sampling and resultant analytical data. 
In order to demonstrate the effectiveness of the direct to MS technology CBS towards real 
world applications, it was applied as a screening procedure to the final effluent of 6 WWTF. In 
addition to the CBS determination of the target pharmaceuticals in the final effluent samples, a 
Introduction 
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traditional SPE methodology which has been used in the literature for the analysis of 
pharmaceuticals in similar sample matrices was used as a comparison. In order to test the 
agreement of the CBS technology with the conventional SPE technique, CBS was applied to the 
WWTF samples using two calibration schemes; 1) external calibration and 2) standard addition 
calibration. The SPE extracts were calibrated using external calibration. In all cases the method 
response was calibrated as a ratio of analyte response to spiked internal standard so as to correct 
for matrix effects and provide a total concentration determination, allowing the direct comparison 
of SPE to SPME technologies.  
 
3.2 Experimental 
 
3.2.1  Sampling 
 
 The final effluent of 6 WWTFs were sampled for the CBS/SPE comparison study. Sites 
#1, #2 and #3 were WWTFs located in urban environments employing a conventional activated 
sludge treatment process followed by clarification, nitrification and treatment with ultra-violet 
(UV) light prior to discharge. Site #3 operated using the same processes at sites #1 and #2, however 
it had an additional sand filtration step prior to UV treatment. Sites #4, #5 and #6 were in rural 
environments and employed varied treatment processes. Site #4 operated using an activated sludge 
process followed by chlorination and subsequent de-chlorination, while site #5 employed a 
sequence batch reactor followed by sand filtration and UV treatment. Finally site #6 is an extended 
aeration facility with sand filtration followed by ozone disinfection prior to discharge. At each of 
the WWTFs final effluent was sampled using a 1 L amber glass bottle and stabilized with 0.2 g/L 
of sodium azide and 0.05 g/L of ascorbic acid. Sample pH’s were 7.0, 6.6, 7.2, 6.9, 7.4, and 6.9 
Experimental 
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respectively. Characterization such as total organic carbon determination and sample conductivity 
were not performed as this was a proof of concept study designed to compare CBS to SPE. Samples 
were then stored in a cooler on ice with a tightly sealing lid so as to ensure no light exposure. After 
sampling, the final effluent grab samples were taken back to the lab where the pH was measured 
followed by spiking of the standards and internal standards at the concentrations used for the 
calibration method to be employed. Of the 6 WWTF final effluents sampled, the pH was measured 
to be greater than 6.5 or less than 7.5 and was not adjusted. Samples were then stored at 5°C 
overnight followed by extraction and analysis the next day. 
 
3.2.2 WWTF effluent sample analysis method: SPME/ CBS 
 
 The CBS devices used for this analysis are those described in section 2.2.2. Sample 
volumes of 9 mL were used in this study. Extractions were performed for 10 minutes using an 
agitation rate of 1200 rpm by the use of a bench top mixer. After extraction, blades were rinsed in 
MS grade water for 5 seconds using vortex agitation and allowed to dry prior to instrumental 
analysis. A desorption solution of composition 95:5, methanol/water with 12 mM ammonium 
acetate and 0.1 v% formic acid was used. Once CBS devices were oriented in front of the mass 
spectrometer, 15 µL of the desorption/ ionization solution was applied to each blade and left to 
rest for 20 seconds prior to the initiation of a 30 s ESI event by application of a +4 kV potential 
difference. The MS parameters and target compounds are the same as those mentioned previously 
and information such as SRM transitions monitored are available in Appendix #1. 
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3.2.2.1 Standard addition calibration 
 
 In order to provide a matrix match calibration for comparison to external calibration 
methodologies, standard addition calibration (SA) was employed. Calibration curves were 
formulated in the sample matrices immediately after sampling by spiking the target analytes 
outlined in the previous chapter at 0, 10, 50, 100, 250, 500, 1000, and 2000 ng/L with internal 
standard at 100 ng/L in all samples. For the target compounds carbamazepine, ranitidine, and 
codeine calibration was performed using all standard addition calibration points. For all other 
target compounds, the range of 0-250 ng/L was employed as two apparent regions of linearity were 
observed. Salbutamol was calibrated over the range of 0-100 ng/L as this phenomenon was more 
pronounced as no internal standard correction was performed as this internal standard was not 
available at the time of experimentation. At each point of the calibration curve analysis was 
performed in triplicate with the exception of the zero point spiked with internal standard, where 5 
replicate extractions were performed. In this case both sides of the CBS devices were analyzed 
giving n=10 replicates. When performing calibration, the concentration was determined by 
extrapolation to a y-value associated with the response of a blank rather than a y value of 0 
corresponding to the x-intercept of the line of best fit as many compounds demonstrate a relevant 
non-zero blank response. 
3.2.2.2 External calibration 
 
 External calibration (EXT) is often favorable as one calibration curve can be used to 
calibrate multiple samples. For this reason it was employed in this study so as to identify whether 
it is a viable alternate to matrix match calibration, which is more time consuming to perform and 
requires a larger total sample volume. Of course, with a sample matrix such as WWTF effluent, 
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analyte sorption to suspended particulate or interaction with other dissolved substances will affect 
the free concentration of analyte sampled by SPME devices. To account for this, while performing 
external calibration it was imperative to have internal standard spiked so as to correct for these 
sample characteristics and matrix effects and facilitate the determination of total concentration 
allowing for a comparison to the other methodologies used (matrix match SPME, SPE). 
 External calibration curves were formulated in MS grade water which used the same 
extraction and analysis procedure as outlined in the standard addition calibration method. 
Calibration points were spiked at 1, 5, 10, 50, 100, 500, 1000 and 2200  ng/L with internal standard 
spiked at 100 ng/L. Calibration curves were formulated by taking the ratio of analyte response to 
internal standard response and weighed by least squares as the error was observed to be 
heteroscedastic with concentration. The ratio of signal to internal standard of the zero spike point 
used in the standard addition curves was then calibrated using this external calibration line of best 
fit. 
 
3.2.3 WWTF effluent sample analysis method: SPE 
 
 The SPE methodology used was applied in triplicate and is that of a common SPE 
procedure which is documented to have been used for this purpose in the literature.5 The sample 
volume utilized in this particular application is 100 mL spiked at 400 ng/L with internal standard. 
Waters Oasis-HLB, 60 mg, SPE cartridges were first preconditioned using 5 mL of methanol 
followed by 5 mL of water using vacuum assistance. The 100 mL sample was then passed through 
the SPE cartridge using vacuum assistance at a controlled draw rate. SPE cartridges were then 
dried by vacuum and eluted using 5 mL of methanol. This methanol concentrate was then 
evaporated to dryness under nitrogen flow, followed by reconstitution in 1 mL of a 50:50 
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methanol/water solution. This reconstituted sample was then analyzed using LC-MS/MS. 
Response was calibrated by ratio of analyte to internal standard and was compared to a calibration 
curve generated in spiked organic solvent (50:50 methanol/water) over the range of 10 ng/L to 
2.2 µg/L. Specifics such as LC method and MS parameters are available in Appendix #1. Samples 
were verified to have not degraded due to microbial or other processes by comparison of internal 
standard response obtained from the WWTF samples spiked after sampling to that of MS grade 
water which was spiked the day all sample SPE extractions were performed. 
3.3 Results and discussion, SPME v.s. SPE 
 
 In general, good agreement between the analysis methodologies was observed. Of the 
target compounds, all were detected by the SPE methodology with the exception of monensin. 
Though monensin was detected by the use of the CBS methodology, it is not reported here as this 
was a comparative test and no confirmation could be made that monensin was in fact in the sample. 
Of the compounds targeted, carbamazepine, codeine and ranitidine were observed to have the 
highest concentrations of all target compounds at each of the test sites with the exception of site 
#6. The analysis of site #6 only yielded a positive result for carbamazepine, which was detected at 
a concentration of 19 ng/L by SPE, and had a value around the LOD of 9 ng/L for the CBS 
methodology. This result could in part be explained by the fact that Site #6 was the only WWTF 
sampled which employed ozone disinfection, which may have played a role in pharmaceutical 
degradation. Of sites #1-5, the next most prevalent and quantifiable of the target pharmaceuticals 
were propranolol, methadone, salbutamol and erythromycin. While paroxetine, fluoxetine, and 
sertraline were below the LOQ of the method but detectable by CBS and verified to be present by 
SPE. A summary of the results can be seen in Table 3.1. For comparative sake, as the error 
associated with the quantification by a standard addition curve is extrapolated and given as a 
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confidence interval, the error associated with the CBS external calibration was also converted to a 
95% confidence interval by multiplication of the standard deviation by the appropriate two tail, 
α=0.05, t-value.71 The error associated with the SPE determination was left as a standard deviation 
as the value determined by this method was assumed to be correct. Diazepam was not included in 
the results table as only a very small peak associated with it was found in the SPE extracts, making 
quantification difficult and unreliable. This low response was corroborated by the observation of 
above blank response when performing CBS analysis of the WWTF effluent samples, though none 
were above the method LOD of 33 ng/L with the exception of the standard addition calibration of 
Site #4, which yielded 42 ng/L, with a +/- 2 ng/L 95% confidence interval (CI). Interestingly, the 
region of the chromatogram in which diazepam would be detected by LC-MS/MS analysis of the 
SPE extracts is in a region of high noise, as evident in Figure 3.1. 
 
Figure 3.1: Chromatographic background for the SRM transition of m/z 285+ to 193+, relating to 
the MS/MS fragmentation of diazepam 
 
This of course will effect direct to MS determinations of diazepam as well, and is the likely reason 
why an LOQ of less than 100 ng/L was not attainable for the CBS methodology under these 
conditions.  
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One interesting observation was that upon LC separation of the SPE extracts it was noted 
that there were multiple compounds that achieved chromatographic separation which 
demonstrated the same SRM transitions used to target propranolol and paroxetine. As CBS is a 
direct to MS approach, it is unable to differentiate these compounds from one another. As a result, 
if truly quantitative determination of these compounds is to be conducted using direct to MS 
approaches additional separation procedures are required such as ion mobility spectrometry (IMS), 
or additional ion fragmentation (MSn). For example, Figure 3.2 demonstrates a side by side 
comparison of a paroxetine standard to the SPE extract of Site #1, while Figure 3.3 demonstrates 
a side by side comparison of a propranolol standard to the SPE extract of Site #2. 
 
 
 
Figure 3.2: Chromatographic background for the SRM transition of m/z 330+ to 192+, relating to 
the MS/MS fragmentation of paroxetine 
 
Figure 3.3: Chromatographic background for the SRM transition of m/z 260+ to 116+, relating to 
the MS/MS fragmentation of propranolol 
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Site #1 
SPE 1063(1) 1769(30) 287(7) 13(1) 15(3) 61(1) D 57(2) 83(5) 35(5) 
SA 826(156) 1628(223) 370(30) 42(8) D 27(12) D D 43(19) 83(14) 
EXT 939(60) 1318(252) 362(20) 12(5) D 75(3) D D N/A 20(9) 
Site #2 
SPE 808(12) 875(136) 235(62) 19(7) 24(3) 14(1) D 62(1) 57(3) 44(2) 
SA 769(110) 857(184) 276(56) 45(11) D 17(14) D D 55(15) 60(22) 
EXT 757(61) 643(136) 354(13) 21(2) 71(26) 29(3) D D N/A 16(9) 
Site #3 
SPE 1096(9) 997(2) 509(5) 24(1) D 109(3) D 59(3) 103(6) 38(4) 
SA 1159(75) 1062(134) 720(84) 48(8) D 141(14) D D 54(17) 33(17) 
EXT 1028(164) 744(204) 593(92) 23(21) D 141(37) D D N/A 19(8) 
Site #4 
SPE 101(1) 1569(30) 573(15) 58(2) 12(2) 45(1) D 87(2) 103(1) 64(14) 
SA 113(41) 1427(228) 649(161) 141(24) D 104(31) D D 50(16) 100(43) 
EXT 90(19) 993(361) 651(28) 32(18) D 57(5) D D N/A 19(14) 
Site #5 
SPE 593(12) 504(2) 350(4) 30(1) D 21(2) D 45(1) 61(4) 85(3) 
SA 547(81) 564(92) 416(29) 70(17) D 62(34) D D 35(12) 93(23) 
EXT 678(75) 523(63) 438(30) 23(6) D 33(3) ND D N/A 52(14) 
 
Table 3.1: SPE vs SPME comparison for the determination of target pharmaceutical at 5 WWTF sites 
 +/- error in brackets represents 95% C.I. for CBS standard addition(SA) and CBS external calibration(EXT), for SPE it is standard deviation 
 D = >LOD, SPE extract listed as D has peak in sample, but quantified at a value less than the lowest calibration point 
 ND = not detected 
 As no internal standard was available for salbutamol SPME determinations of this compound, which are not a matrix match calibration, would determine free 
concentration and would therefore not be comparable.
41 
 
 Upon literature review, a potential candidate for the compound which is demonstrating the 
same SRM transition as paroxetine is that of reticuline. Both compounds demonstrate the 330 to 
192 transition, with literature references even using this transition for the monitoring of reticuline 
in real samples.72,73 More strikingly is that reticuline is known to occur in the urine of opium users 
and those who have used codeine or morphine.74 As codeine was detected in the WWTF effluent, 
and even though we did not target reticuline in this study, one would expect to find this compound 
in such a sample matrix. 
 In the case of propranolol, no specific compounds have been identified which may account 
for these particular peaks associated with the SRM transition of m/z 260+ to 116+. However, 
propranolol is a member of a group of β–blocker pharmaceuticals including atenolol, metoprolol, 
oxpremolol and pindolol, all of which having the ability to produce a m/z = 116+ daughter ion, as 
demonstrated in Figure 3.4 due to their shared functionality. 
 
Figure 3.4: Formation of the m/z = 116+ daughter ion in propranolol like molecules  
 
What could be occurring here is that metabolites or environmental reaction products 
associated with any of these compounds are able to form a 260+ ion, enabling it to pass the first 
quadrupole and form the 116+ daughter ion. Of course, alternate SRM transitions could be selected 
which are specific to the differentiating region of these molecules but as this occurrence has not 
been reported, the m/z = 116+ was selected as it was the most prevalent daughter ion. With this in 
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mind, and what is perhaps more likely to be occurring is that the metabolites of propranolol 
themselves are present in the sample and are undergoing in source fragmentation, generating 
propranolol and hence the m/z = 260+ ion. This hypothesis is supported by the knowledge that 
propranolol is known to have a large number of metabolites, many of which possess attached 
functionalities such as glucuronide.75 These metabolites are more polar than propranolol and hence 
are less retained by the column and elute earlier than propranolol, as observed in the SPE extract 
separations.75 This explanation may also hold true for the similar observation made of paroxetine 
chromatograms if the compound is in fact not reticuline. 
3.4 Summary 
 
 Coated blade spray can certainly offer a rapid and quantitative methodology for the 
screening of target pharmaceuticals in surface waters and the final effluent streams of WWTFs. In 
the application discussed above, the merits of CBS as a technique were underlined by its truly 
rapid nature and requirement for limited sample preparation compared to the conventional method, 
SPE, which it was compared to.  When residual pharmaceuticals were in the quantifiable range, 
agreement between the CBS methodologies and the SPE determination was observed. 
Additionally, where SPE could validate that a target compound be present, CBS was able to detect 
it given the achievable LOD’s for all targets being below the 50 ng/L level. Of course, some 
limitations of CBS were identified. Perhaps the most significant one being the observation of 
compounds in the samples which demonstrated the same SRM transitions as those monitored for 
the compounds targeted. Of course, with the implementation of a more comprehensive screening 
of SRM transitions this issue may be addressed. Alternatively, with the implementation of ion 
mobility or MSn these compounds could be differentiated from one another while still providing a 
direct to MS procedure for the rapid quantitation of target analytes.53,76
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4. Chapter #4: Development of a recessed extraction phase device 
for the sampling of tissue 
  
4.1 Introduction 
 
 When investigating complex sample matrices, direct immersion (DI)-SPME is typically 
employed as a broad range of analytes are often of interest for both targeted and untargeted studies. 
Of course, there are a range of difficulties associated with DI-SPME, including the co-extraction 
of undesirable compounds resulting in matrix effects and/or fouling of the extraction phase causing 
poor extraction efficiency and reproducibility.31 Methodologies by which to protect SPME fibers 
from the chemical complexities of DI samplings include membrane protected SPME where, for 
example, a hollow cellulose or polypropylene membrane is placed over an SPME fiber in order to 
limit the extraction of high molecular weight compounds which could interfere with analysis.77,78 
In addition, the application of protective over-coatings such as polydimethylsiloxane (PDMS) on 
top of polydivinylbenzene (DVB)/PDMS SPME fibers have demonstrated the ability to provide a 
smooth fiber surface limiting coating fouling and adhesion of matrix constituents onto the fiber 
resulting in increased fiber lifetime and reproducibility.31,79 These developments, though 
significant, do little in the way of preventing mechanical damage to an SPME fiber resulting from 
the puncture of, or passage through, tough protective tissue. Methods by which to physically 
protect sorbent coatings from mechanical damage include “in-groove” SPME, where an extraction 
phase is glued into a depression on a wire as to protect it from smearing onto the inner wall of a 
protective housing used to puncture vial septa.80 Alternatively, the SPME-Arrow incorporates an 
extraction phase which has been enlarged in order to increase method sensitivity and incorporated 
into a telescoping region which is shielded inside a protective tube during septa puncture.81,82 
Introduc i n 
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Though both devices may be well suited for high-throughput applications, their size and continued 
incorporation of a sheathing needle do not prove advantageous for in-vivo samplings where the 
sampler should be simple to operate and as small as possible in order to limit damage to the target 
tissue. For these reasons no available device was suitable for the desired application, that of the 
rapid administration of an SPME device through fish tissue, for the targeted analysis of 
anthropogenic compounds in fish tissue. 
Presented herein is a device which is miniature in nature and able to directly puncture 
robust sample matrices with no additional supporting hardware. Due to this, the device in question 
is able to directly puncture fish scales, enabling the sampling of wild fish for a range of purposes 
including environmental exposure studies. This was accomplished by applying a sorbent into a 
recession around the circumference of a stainless steel support, as shown in Figure 4.1. The device 
was designed to have the surface of the coated region possess a diameter less than or equal to that 
of the solid support in order to protect the leading edges of the coating during puncture into, and 
withdrawal out of, tissue.  
 
Figure 4.1: Side by side comparison of the recessed SPME needle as a custom projectile to that 
of the traditional method of insertion of an SPME fiber through protective tissue 
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This development enables a maximum surface area of sorbent per unit of puncture hole diameter 
to enter the sample matrix as a larger sheathing needle support is no longer required. This 
characteristic maximizes extraction phase surface area, and therefore sensitivity. Which is essential 
for shorter, more timely, extractions thus minimizing the invasiveness of the sampling. For 
example, even though a traditional nitanol based bio-SPME fiber possesses a relatively small outer 
diameter of 200 µm, a much larger 720 µm sheathing needle is required to guide said fiber through 
protective biological tissue such as fish scales.57,59,60 Hence, without the need of an external 
protective housing,  the SPME needle was enlarged to the size of a traditional 24 gauge (570 µm) 
hypodermic needle providing more surface area which could translate into much shorter sampling 
times than the traditional bio-SPME fiber while still reducing the size of the resulting puncture 
hole.83 
The device was further applied to the on-site sampling of wild muskellunge in order to 
demonstrate the rapid sampling ability of the developed device. This particular species of fish was 
selected for this demonstration due in part to their relatively long life expectancy, identifying this 
particular species as a prime target given that fish in general have already been identified as 
susceptible to bioconcentration of select pharmaceuticals.20,84 
 
4.2 Experimental 
4.2.1 Materials and reagents 
The pharmaceuticals paroxetine, diazepam, and codeine were purchased from Cerilliant of 
Sigma-Aldrich (Roung Rock, TX, USA) while salbutamol, monensin, erythromycin, ranitidine 
and carbamazepine were purchased from Sigma-Aldrich (Oakville, ON, Canada). The 
polyunsaturated fatty acids (PUFAs) used, arachidonic acid (ARA), docosahexaenoic acid (DHA) 
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and eicosapentaenoic acid (EPA) were purchased from Cayman Chemical Company (Ann Arbour, 
MI, USA). Stainless steel needles to be converted into SPME needles were obtained from a local 
craft shop, while the 1.5 cm C18-mixed mode SPME fibers used in the comparative studies were 
kindly provided by Supelco (Bellefonte, PA, USA) and modified to possess a coated region of 1 
cm. SPME needles and the mixed mode SPME fibers both had a coated region length of 1 cm. For 
chromatographic separations and standard preparation the MS grade methanol, acetonitrile, and 
water were obtained from Fisher Scientific while the salts formic acid and ammonium acetate were 
purchased from Sigma Aldrich (Oakville, ON, Canada). The dimethylformamide (DMF) used  in 
the over coating procedure was purchased from Sigma Aldrich. Plastic 300 µL vials and amber 
2mL glass vials along with pre-pierced PTFE/Silicon septa used in puncture tests were purchased 
from Canadian Life Sciences (Peterborough, ON, Canada). For sample matrices, whole fish and 
salmon steaks were purchased from a local grocery store. HLB particles used were obtained from 
Waters (Wilmslow, UK) while the C18 particles used were obtained from Supelco. 
 
4.2.2 Manufacture of recessed SPME devices 
 
 Recessed SPME devices were manufactured so as to possess a 1 cm coated region by 
protecting all regions of the stainless steel pins used with silicon, leaving exposed only the region 
which is to be recessed. The protected pins were then placed in 37wt% hydrochloric acid and 
sonicated at room temperature. The duration of sonication was used to determine the depth of 
recession formed into the steel pins, and would depend on the thickness of the coating to be applied 
within this recession. As the coating thickness used for the devices investigated here was that of 
10 µm, recessions of 10-15µm were formed using a 10 minute sonication time. Etched pins were 
then removed from the acid, rinsed in water using sonication 3 times for 5 minutes, followed by a 
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quick rinse in methanol and dried at 80°C for 5 minutes. HLB-PAN or C18-PAN extractive 
coatings were then applied using a proprietary coating procedure. After coating, the extraction 
phase on the tip of the device, which was not recessed, was removed with a razor blade. 
 
4.2.3 Analysis of Pharmaceuticals, device validation  
 
Prior to use, all recessed SPME needles and mixed mode fibers were pre-conditioned in 
1.5 mL of 50:50 v/v water-methanol for 30 minutes at 1500 rpm. Extractions for the comparison 
of SPME needles which were and were not punctured through septa (5 of each) in order to access 
the sample solution were performed from 1.6 mL of MS grade water spiked with sertraline, 
fluoxetine, paroxetine, diazepam, salbutamol, ranitidine and codeine at a concentration of 15 µg/L. 
Extractions were performed for 2 minutes using vortex agitation. Once completed, the SPME 
needles were removed from the sample solution, washed for 5 seconds in MS grade water under 
vortex agitation and desorbed into 300 µL of a methanolic solution at 1500 rpm for 10 minutes. 
No carry-over of analyte on the SPME devices was verified by performing a second desorption. 
For the intra needle reproducibility study, all recessed SPME needles and mixed mode fibers were 
pre-conditioned in a 50:50 water-methanol solution for 30 minutes at 1500 rpm. Extractions were 
subsequently performed by pushing the needle through the septa in order to access the sample 
solution which was 1.6 mL of  pH = 7.4, 1 M phosphate buffer solution made with MS grade water 
spiked with sertraline, fluoxetine, paroxetine, diazepam, salbutamol, ranitidine and codeine at a 
concentration of 30 ng/mL. Extractions were performed for 2 minutes using vortex agitation. Once 
completed, the SPME needles were removed from the sample solution, washed for 5 seconds in 
MS grade water under vortex agitation and desorbed into 1.5 mL of MS grade methanol (Fisher) 
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at 1500 rpm for 10 minutes. No carry-over of analyte on the SPME devices was verified by 
performing a second desorption. 
 
4.2.4 Analysis of fatty acids in salmon, an in lab proof of concept 
 
 Fresh, refrigerated salmon steaks were purchased from a local grocery store and left to 
reach room temperature for one hour prior to extraction. HLB-PAN, C18-PAN SPME needles, 
and mixed mode SPME (C18 with strong cation exchanger) fibers were conditioned as described 
above prior to being inserted into the salmon steak and left for one hour, having three of each 
directly inserted into the muscle tissue. In order to take full advantage of the robust SPME needle, 
an additional three HLB-PAN SPME needles were pushed through the protective flesh into the 
underlying tissue for one hour. After extraction, the devices were washed 2 times for 5 seconds in 
MS grade water using vortex agitation and desorbed in 100% ACN for one hour at 1500 rpm.85 
No carry-over of analyte on the SPME devices and mixed mode SPME fibers was verified by 
performing a second desorption. Newly fabricated and never used SPME needles were used for 
each extraction unless otherwise specified. Quality control injections were used to correct 
experimental data to the day of instrument calibration. 
4.2.5 On-site sampling of angled muskellunge 
Wild muskellunge were sampled from two locations in southern Ontario in an effort to 
obtain data which would be able to differentiate the two populations from one another based on 
the presence or absence of contaminants in the sampled specimens. Sampling was performed in 
accordance with the proper animal care protocols (AUPP# 14-06). The SPME needles used in this 
application possessed a HLB-PAN coating, and were stored in 50:50 methanol/water prior to use. 
Sampling at the Georgian Bay location was performed by pushing the devices into each of the fish 
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(n=2, 4 needles per fish), while at the Ottawa River site SPME needles were administered as a 
projectile (n=2, 5 needles per fish) so as to expedite the sampling process. The extractions were 
performed mid-way along the back of each fish, and extractions were performed for 10 minutes. 
Once complete, the devices were removed and rinsed in 1.5 mL of MS grade water and 
subsequently stored in 300µL glass vials on ice. Upon returning to the lab, samples were stored at 
-80°C until the time of desorption. SPME needles were desorbed in 250 µL 80:20 methanol/water 
for 3 hours at 1200 rpm.  
4.2.6 Instrumental analysis 
 
4.2.6.1 Instrumental method #1: Pharmaceuticals 
 
Samples were run on a TSQ-Vantage coupled to an Accela Auto sampler and LC pump 
(Thermo Scientific, San Jose, USA). Separations were performed on an Ascentis Express F5 PFP 
HPLC column (2.1mm x 100 mm, 2.7µm). A ternary mobile phase system was employed. Mobile 
phase A B and C were 100% water, acetonitrile and methanol respectively. All mobile phases 
contained 0.1 v% formic acid. Specifics such as solvent gradient, ionization conditions and SRM 
transitions can be seen in Table 4.1. 
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Table 4.1: Chromatographic solvent gradient along with positive H-ESI ionization conditions 
with SRM transitions for the analysis of select pharmaceuticals86 
Mobile phase gradient 
Time (min) 
Percent composition 
Flow (µL/min) 
A B C 
0 90 5 5 300 
0.5 90 5 5 300 
7 0 50 50 300 
12 0 25 75 300 
15.3 0 25 75 300 
15.5 90 5 5 300 
17.5 90 5 5 300 
 
Mass spectrometer conditions 
Spray voltage: 1300V 
Vaporizer temperature: 275°C 
Sheath gas: 30 
Auxiliary gas: 30 
Sweep gas: 2 
Capillary temperature: 275°C 
 
SRM parameters by compound 
Compound Parent (m/z) Daughter (m/z) Collision energy (eV) S-Lens 
Diazepam 285.056 193.079 30 115 
Ranitidine 315.128 176.024 16 92 
Codeine 300.134 152.059 60 120 
Paroxetine 330.129 192.097 19 133 
Fluoxetine 310.121 44.157 13 76 
Sertraline 306.057 158.955 29 75 
Salbutamol 240.147 148.071 16 79 
 
 
4.2.6.2 Instrumental method #2:PUFAs in Salmon 
 
Samples were run on a TSQ-Vantage coupled to an Accela Auto sampler and LC pump 
(Thermo Scientific, San Jose, USA). Separations were performed on an X-Bridge C18 HPLC 
column (2.1mm x 150 mm, 2.5µm). A binary mobile phase system was employed. Mobile phase 
A consisted of 90% water and 10% methanol while mobile phase B was composed of 80% 
methanol and 20% acetonitrile. Both Mobile phase A and B were modified to contain 5 mM 
ammonium acetate. Specifics such as solvent gradient, ionization conditions and SRM transitions 
can be seen in Table 4.2. 
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Table 4.2: Chromatographic solvent gradient along with negative H-ESI ionization conditions 
with SRM transitions for the targeted analysis of select PUFAs85 
Mobile phase gradient 
Time (min) 
Percent composition 
Flow (µL/min) 
A B 
0 40 60 300 
1 40 60 300 
2 5 95 300 
5 0 100 300 
6 0 100 300 
6.5 40 60 300 
8 40 60 300 
 
Mass spectrometer conditions 
Spray voltage: -2600V 
Vaporizer temperature: 275°C 
Sheath gas: 30 
Auxiliary gas: 30 
Sweep gas: 2 
Capillary temperature: 275°C 
 
SRM parameters by compound 
Compound Parent (m/z) Daughter (m/z) Collision energy (eV) S-Lens 
Arachidonic acid 303.431 260.610 17 132 
Docosahexaenoic acid 327.098 284.672 16 134 
Eicosapentaenoic acid 301.103 263.631 16 133 
 
4.2.6.3 Instrumental method #2: HRMS analysis of muskellunge extracts 
 
Samples were run on an Exactive coupled to an Accela Auto sampler and LC pump 
(Thermo Scientific, San Jose, USA). Separations were performed on a Discovery HS F5-3 column 
(2.1mm x 100 mm, 0µm). A binary mobile phase system was employed. Mobile phase A consisted 
of water while mobile phase B was composed of acetonitrile. Both Mobile phase A and B were 
modified to contain 0.1 v% formic acid. Specifics such as solvent gradient, ionization conditions 
and MS conditions can be seen in Table 4.3. Instrumental response was verified to be stable by the 
repetitive injection of a Pooled QC sample over the course of the experimental run. 
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Table 4.3: Chromatographic solvent gradient along with positive H-ESI ionization and HRMS 
conditions for the untargeted analysis of muskellunge extracts 
Mobile phase gradient 
Time (min) 
Percent composition 
Flow (µL/min) 
A B 
0 100 0 300 
3 100 0 300 
25 10 90 300 
34 10 90 300 
35 100 0 300 
40 100 0 300 
 
Mass spectrometer conditions 
Spray voltage: +3900V                                    
Vaporizer temperature: 275°C 
Sheath gas: 35 
Auxiliary gas: 5 
Sweep gas: 0 
Capillary temperature: 275°C 
 
HRMS parameters  
Scan range (m/z) Lock mass (m/z) Inj. Time (ms) Resolution  
100-1000 391.2849 100 50 000  
 
4.2.6.4 SEM and EDX characterization 
 
Scanning electron microscope (SEM) images and energy-dispersive x-ray (EDX) spectra 
were obtained using a Merlin SEM and an Apollo XL-SDD detector respectively operated by 
WATLab at the University of Waterloo, samples were deposited onto adhesive carbon tape and 
coated in gold prior to analysis. 
4.3 Results and Discussion 
 
4.3.1 Demonstration of rigidity of the recessed device 
 
Preliminary experimentation with the recessed SPME needles employed HLB particles 
suspended in a PAN glue as extractive coatings due to the wide variety of compounds which 
demonstrate affinity for HLB.86 In these experiments SPME needles were used to puncture fish 
scales, cardboard, and plastic. For these tests, in order to fully test the robustness of the SPME 
needle as well as to facilitate rapid, one-handed sampler introduction, SPME needles were 
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incorporated into custom projectiles which were fired from an unmodified airsoft gun. The firing 
speed was approximately 90 m/s to simulate aggressive handling and demonstrate the ability of 
the technology to be used as a rapid sampling tool for in-vivo applications. It was quite evident 
that needles which did not incorporate a recession along the coated region were more susceptible 
to damage upon impact and puncture, as demonstrated in Figure 4.2. 
 
 
Figure 4.2: Comparison of recessed and non-recessed coating damage resulting from the rapid, 
gun-assisted, puncture of fish scales. A) recessed coating before puncture, B) non-recessed 
coating before puncture, C) recessed coating after puncture, D) non-recessed coating after 
puncture 
 
Upon the determination that the SPME needle did in-fact provide a mechanically robust 
sampling device, the process of puncturing was further validated to not affect extraction of target 
analytes. To assess this parameter, two sets of five SPME needles were used to extract seven 
pharmaceuticals (sertraline, fluoxetine, paroxetine, diazepam, salbutamol, ranitidine, and codeine) 
at 15 ng/mL in water with one set first being forced through septa in order to access the sample.  
As shown in Figure 4.3 method response for the targeted analytes was generally comparable based 
on visual magnitude for both sets of SPME needles studied. Interestingly statistical analysis by 
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ANOVA (α = 0.95) was inconclusive, with only paroxetine (p = 0.45), diazepam (p = 0.10), and 
salbutamol (p = 0.38) demonstrating p values greater than 0.05, identifying method response of 
both treatments to be statistically similar. This observation hints towards some disagreement, 
which is addressed and explained by Figure 4.6 and the subsequent discussion. 
 
Figure 4.3: Comparison of HLB-PAN - SPME needles with and without septa puncture in order 
to access aqueous solution of pharmaceuticals with no internal standard correction 
 
To further determine the effect of septa puncture of a pre-slit septa on the extraction of 
analyte an inter-SPME needle reproducibility study was conducted. This experiment employed 5 
SPME needles which were pushed through the protective septa of the sample vials in order to 
access the sample solution. With no internal standard correction, no observed RSD was greater 
than 14%. An example of the resultant data for the target compounds ranitidine and codeine are 
given in Figure 4.4.  
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Figure 4.4: Inter device reproducibility of HLB-PAN recessed SPME needles for the targeted 
analytes ranitidine and codeine 
 
In addition, intra-SPME needle reproducibility was observed over 15 pre-slit septa 
punctures giving a % RSD <13% for all compounds tested using no internal standard correction. 
The exception to this observation was that of salbutamol, which demonstrated an intra-needle RSD 
of 21%, though this observation was in part explained by the results of the following experiment. 
An additional observation of this particular intra needle study being that over the course of 15 
septa puncture events, no physical damage was observed to occur to the extraction phase. 
After the initial 15 septa punctures, the SPME needles were then pushed through non-pre-
pierced septa in order to determine whether this, more aggressive treatment, would affect the 
extraction of the target analytes or induce mechanical damage to the coating. To accomplish this, 
the same experimental procedure was followed as with the initial 15 puncture events for a total of 
an additional 35 septa punctures. After the conclusion of these 50 total septa punctures, an 
additional 3 extraction, wash, and desorption steps were performed using pre-slit septa in order to 
see if the SPME devices could be regenerated in the event a decrease in response was observed.  
After the conclusion of this study, only slight mechanical damage was noted to have 
occurred to the extractive coatings, as shown in Appendix #3. It should be noted however that this 
damage occurred after 25 puncture events, well past the number of puncture events expected in 
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any future application. Interestingly, though, was the observation that there was a drop in method 
response over the course of the study. This reduction was compound dependent and appeared to 
be related to the polarity, or logP, of the target compounds. Of the target compounds salbutamol 
(logP=1.4), codeine (logP=1.2), and ranitidine (logP=0.8) were observed to have a reduced method 
response after puncture through the non-pre-pierced vial septa. While, the target compounds 
diazepam (logP=2.8), sertraline (logP=5.2), fluoxetine (logP=4.2), and paroxetine (logP=3.2) were 
observed to maintain a constant response over all 50 puncture events. This phenomenon is 
presented in Figure 4.5, where the traces for diazepam and carbamazepine are provided. Also of 
note, the 51st, 52nd, and 53rd samplings through pre-pierced septa were not able to recover the 
coating, leading to the conclusion that alteration to the coating was irreversible under the 
experimental conditions used. 
 
 
Figure 4.5: Inter needle reproducibility for the target analytes diazepam and carbamazepine over 
15 punctured through pre-pierced septa followed by 35 puncturess througha non-pre-pierced septa 
in order to access an aqueous sample solution 
 
 Mechanical damage was quickly ruled out as the cause for this observation, as if this were 
the case there would have been a reduction in response for all of the target compounds, rather than 
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a select few with similar characteristics (logP). As a result, the cause of this reduction was likely 
the result of the chemical modification of the coating itself, as this would allow for the observation 
that compounds with different chemical characteristics would behave differently. In order to gain 
a better understanding of this, SEM images were taken of the surface of the extraction phase for a 
new SPME needle, and one which had been through the 53 septa puncture study. What was 
immediately apparent was the modification of the surface of the extraction phase by the deposition 
of some substance. It was clear that the coating itself was not being removed, as the HLB particles 
were still observable, but rather covered. In order to identify the chemical composition of the 
substance EDX was performed of the coating surface of each device. Unsurprisingly, the EDX 
revealed the substance which had been deposited was composed primarily of silicon and oxygen. 
This of course is the composition of the siloxane septa used, and as such, the conclusion was drawn 
that the septa itself was smearing onto the surface of the extraction phase as it passed through the 
vial septa. Figure 4.6 provides SEM images and EDX spectra of the devices tested. 
 
                          
 
    
Figure 4.6: SEM images and EDX spectra of SPME needles used in the septa puncture study 
 
 Interestingly, the presence of silicon is noted in the EDX of the needle which was new and 
pushed through a pre-pierced septa for storage. This observation leads to the conclusion that there 
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is deposition of silicon onto the coating surface even when pre-pierced specta are used. However, 
this deposition occurs to a much lesser extent than non pre-pierced septa, and does not appear to 
greatly affect analyte extration. What this determination does not clearly explain is why, when non 
pre-pierced septa were used, the extraction of some of the target compounds was not affected. This 
is an interesting observation, as one can clearly see the alteration to the extraction phase is quite 
significant. The initial conclusion to be drawn is that perhaps the extraction of compounds by the 
sorbent is occurring by two phenomenon. In the case of highly polar compounds, such as those 
where a drop in response was observed, the sorptive process is dominated by the interaction of the 
polar functionalities with the HLB extraction phase. In this case, as these polar functionalities of 
the HLB are now covered with a chemically different siloxane, reducing extraction. However with 
less polar compounds the extraction of analyte is more related to non-polar interaction, and as a 
result, the siloxane deposited onto the coating by passage through the septa is participating in the 
extraction of analyte. 
 As high-throughput applications requiring septa puncture events were not the targeted 
application of the recessed SPME device, but rather a demonstration that the device was 
mechanically robust and able to protect the extractive coating from chipping, peeling or scratching, 
no steps were taken to prevent the attachment of the silicon onto the coating surface. If this type 
of application does become an area of interest for such a device, the application of a smooth over-
coating may alleviate this attachment. However, for high-throughput applications requiring the 
puncture of vial septa, technologies such as the SPME-Arrow would likely be advantageous. In 
this case the sorbent would never come in contact with the vial septa. As a result, the smearing of 
siloxane, or other media, onto the extraction phase would not need to be considered as the 
extraction phase is protected by a sheathing needle. 
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4.3.2 Proof of concept, targeted analysis of PUFAs in salmon tissue 
 
Upon the conclusion of the above proof of concept experiments, the recessed SPME needle 
was identified as suitable for the intended purpose of in-vivo sampling. Due in part to its miniature 
size, robust nature, and requirement of no protective housing or sheathing needle. To further 
demonstrate this, the device was applied to the targeted analysis of the poly unsaturated fatty acids 
(PUFAs) docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and arachidonic acid (ARA) 
in salmon. In order to provide a comparison of the SPME needle to a conventional SPME device, 
HLB-PAN and C18-PAN coated SPME needles were compared to mixed mode (MM) SPME 
fibers. Initial studies were able to demonstrate that the HLB sorbent coated needles extracted 3 to 
4 times more PUFAs than C18 coated SPME needles and MM SPME fibers (n=3, Figure 4.7).   
 
Figure 4.7: Comparison of HLB, C18 SPME needles and mixed mode SPME fibers for the 
direct analysis of salmon by the direct puncture of fish muscle tissue for the targeted analysis of 
poly-unsaturated fatty acids. 
 
 In addition, the process of forcing the HLB coated needles through the protective outer 
skin was validated to not affect PUFA extraction (Figure 4.8) by comparing SPME needles (n = 3) 
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which had been forced through the protective tissue to those which had been pushed into muscle 
tissue directly (ANOVA, α = 0.95, EPA p = 0.68, DHA p = 0.56). Interestingly, the SPME needles 
which punctured the skin appear to extract a somewhat greater amount of arachidonic acid than 
those which were pushed into the muscle tissue directly (n = 3). This difference was identified to 
be significant (ANOVA, α = 0.95, p = 0.0015), and one potential hypothesis for this observation 
is that the levels of arachidonic acid may be greater closer to the surface of the tissue, or rather, 
closer to the scales. In any case, it is quite clear that the SPME needle can provide an easy to use 
and comparably reproducible method to traditional SPME fibers for the analysis of whole, 
unmodified tissues and hence in-vivo applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Comparison of HLB SPME needles which had and had not been pushed through the 
protective flesh of salmon in order to sample the underlying tissue for the PUFAs eicosapentaenoic 
acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA). 
  
 So as to identify the true robustness of the device, new SPME needles were used to 
perform repetitive extractions from salmon by directly puncturing through the protective tissue. 
The experiment utilized five separate SPME needles which were each used for nine successive 
samplings through the protective skin of a freshly purchased section of salmon. Over the course 
of this study no mechanical damage was observed to occur and this was verified by microscope 
61 
 
images taken after each extraction. What was observed however was the general darkening of the 
extraction phase over the course of the experiment. In addition, blemished or severely darkened 
regions were observed to occur on the surface of the extraction phase, as evident in Figure 4.9. 
 
 
 
 
 
 
Figure 4.9: Visual comparison of newly made SPME needle compared to the same needle after 
7 extractions from salmon tissue were performed. 
 Upon analysis, this progressive darkening was noted to occur in conjunction with a gradual 
decrease in the amount of the target PUFAs extracted (Figure 4.10). As no mechanical damage to 
the coating was noted, as with the septa puncture event, the initial hypothesis for the cause of this 
observation was that of coating surface alteration. More specifically, the attachment of matrix 
constituent biomolecules causing bio-fouling. In order to determine if bio-fouling of the extraction 
phase had occurred, SEM images and EDX spectra of the devices used in this study were obtained. 
 
 
 
Figure 4.10: Intra SPME needle reproducibility and robustness test for the targeted and 
repetitive analysis of poly unsaturated fatty acids in salmon tissue. 
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Immediately apparent when viewing the coatings under SEM was the gradual deposition 
of a substance onto the surface of the extraction phase, as evident in Figure 4.11. Upon analysis of 
the EDX spectra of the coating surface, it was clear that the abundance of oxygen was increasing 
over successive exposures to the biological sample. This agrees with literature reference where the 
amount of oxygen is observed to increase on the surface of SPME coatings as a result of a bio-
fouling process, where bio-molecules possessing oxygen contained in the sample are deposited 
onto the surface of the extraction phase.87 
 
    
 
 
 
 
 
Figure 4.11: SEM images and EDX spectra of a newly prepared HLB-PAN coating compared to 
devices which were used for the repetative extraction from salmon tissue 3 and 10 times. 
New 3
rd use 10
th use 
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 In order to verify that this bio-fouling was associated with the surface of the coating and 
was not altering the bulk chemistry of the extraction phase further testing was required. To 
accomplish this, the extraction phase of an SPME needle which had been used for 10 extractions 
in salmon tissue was stripped off of the solid support using a razor blade. EDX spectra were then 
obtained for the surface of this coating and for the region of the coating which would have been in 
contact with the solid support, and would not have had direct exposure to the biological sample 
matrix. The results of this are presented in Figure 4.12, and clearly show that the underside of the 
coating does not demonstrate elevated oxygen levels, and is rather similar to a never used coating. 
With this, the conclusion could be drawn that yes, bio-fouling was occurring as a result of the 
deposition of matrix constituents containing oxygen onto the surface of the extraction phase. 
 
 
 
 
 
 
Figure 4.12: EDX spectra of top and bottom of bio-fouled SPME coating demonstrating the 
attachment of bio-molecules to the coating surface 
 
4.3.3 Over-coating procedure development 
 
 In an effort to limit the bio-fouling of the presented device, it was important to investigate 
a methodology which would alleviate such a process from occurring. One such application which 
Bottom (facing metal)  Top (coating surface)  
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has been used to great success in food analysis, as well as bio-analysis, is that of the application 
of a smooth over-coating.31,88 For the purposes of this particular application, poly-acrylonitrile was 
chosen as the desired over-coating chemistry to be employed as it has already incorporated into 
the extractive coating as the glue which binds the HLB extraction phase into place, and is known 
to be a biocompatible polymer.87 The general process used to apply the HLB-PAN over-coating 
was as follows: this device would have the extractive coating applied as usual, and then have an 
appropriate over-coating procedure applied to the device. 
 The solution used to perform the over-coating procedure was a 10 wt% solution of PAN in 
the solvent DMF. This solution was brought to 90 °C for 60 minutes, providing a homogeneous 
solution of PAN/DMF. A dip coating procedure was employed to apply the PAN over-coating, the 
thickness of which was controlled by variation of the withdrawal speed from the over-coating 
solution mixture (due to viscosity, fast withdrawal results in more deposited material). Upon 
withdrawal from the solution the device was immediately cured at 120 °C for 1 minute so as to 
evaporate the DMF and polymerize the PAN. The application of multiple layers of the PAN over-
coating was also investigated to determine whether this could perhaps provide a more uniform 
surface. Table 4.4 outlines a selection of the procedures tested as a part of this study, along with 
corresponding total coating thickness while Figure 4.13 shows SEM images of the over-coated 
surfaces. 
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Table 4.4: Over-coating application parameters and resultant overall coating thicknesses 
Over coating 
Process 
Metal 
(µm) 
Metal + 
Coating (µm) 
Metal + Coating in 
recess region (µm) 
Total coating 
thickness (µm) 
No OC 594 605 570 6 
1x 0.5mm/s 592 603 564 6 
3x 0.5mm/s 593 604 576 6 
5x 0.5mm/s 593 606 580 7 
1x 1mm/s 597 606 579 6 
3x 0.1mm/s 586 598 574 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: SEM images of select PAN overcoatings prepared using different methodologies 
 
1 x 0.5mm/s 
3 x 0.5mm/s 
5 x 0.5mm/s 
1 x 1 mm/s 3 x 0.1 mm/s 
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Interestingly, when considering the 0.5 mm/s withdrawal over-coatings procedure, the application 
of multiple layers of PAN did not significantly increase the thickness of the resultant coating. For 
instance, even with a total of 6 layers of PAN or PAN-HLB, the coating thickness was only 
observed to be 7 µm. As is evident by the SEM images in Figure 4.13, the 5 µm HLB particles 
themselves become less visible as successive over-coating layers are applied demonstrating that 
the application of multiple layers was beneficial. Most importantly, as more layers were applied 
the smoother the coating became. The hypothesis for these observations is that of, when the already 
coated device is placed into the PAN/DMF mixture for over-coating some or perhaps a significant 
amount of the PAN glue already deposited is partially dissolved. However, due to the viscosity of 
the solution, it will not migrate away from the surface of the coating, but rather be redistributed 
around the particles when the next layer is applied. Alternatively, the next layer of PAN over-
coating is preferentially being deposited into the valleys of the existing coating giving the same 
result of a smoother coating surface. When coating withdrawal speeds are compared, it is evident 
that the 0.1 mm/s tests were not of any significant benefit, while the 0.5 mm/s procedure was able 
to provide a more homogeneous surface topography. Most importantly, however, was that of the 
1 mm/s withdrawal procedure, where a more thick and continuous PAN layer was deposited, 
compared to the somewhat porous nature of the 0.5 mm/s procedure. As a result, the over-coating 
procedure applied in the preliminary over-coating evaluation studies was as follows: 5 layers of 
0.5 mm/s was applied so as to provide a smooth surface, followed by a 1 mm/s over-coat in order 
to achieve a non-porous surface. Figure 4.14 provides a visual representation of what this resultant 
over-coating procedure provided. 
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Figure 4.14: Visual representation of the final PAN overcoating employed for the recessed 
SPME devices 
 
 In order to assess the ability of the developed over-coating procedure to protect the recessed 
SPME coating from bio-fouling, the same experimental conditions which resulted in bio-fouling 
were replicated with over-coated devices. Teflon over-coated devices were also incorporated into 
this study, the procedure for application being developed by Dr. Emanuela Gionfriddo and Dr. 
Ezel Boyaci. In addition, a variation of the post extraction washing step was implemented.  Rather 
than 100% water, 10% acetone in water was used as this had been identified to prove beneficial in 
some, unpublished, cases when performing extractions from complex sample matrices using 
SPME. For this study, 3 devices were used for each permutation of experimental conditions 
totaling 36 devices. For example, 3 device with PAN OC had the water wash procedure, and 3 
devices with PAN OC had the acetone wash procedure. The results of this study for the target 
compound EPA are presented in Figure 4.15. 
HLB + PAN over-coat PAN over-coat Bare metal 
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Figure 4.15: Comparison of non over-coated, PAN, and Teflon over-coated recessed SPME 
devices for the targeted analysis of PUFAs in salmon with varied wash procedures. 
 What was immediately apparent was that there was no significant difference between 
devices which possessed an over coated region (ANOVA, α = 0.95). This conclusion was valid for 
all over coating procedures, p values of greater than 0.05 were observed in all cases, as shown in 
Figure 4.15, when the replicate first and fourth extractions were compared. In addition, the drop 
in amount of PUFAs extracted resulting from the bio-fouling of the surface of non-over coated 
devices was identified to be significant (p < 0.05), irrespective of the washing conditions used.  
4.3.4 Preliminary Results: application of recessed SPME to angled muskellunge 
 
 In conjunction with the aforementioned device development and validation was the 
implementation of the SPME needle for the targeted analysis of anthropogenic compounds, 
specifically pharmaceuticals, in wild muskellunge tissue. Upon inspection of the recessed devices 
used in this application, some bending and device deformation was noted to occur during the 
Georgian Bay samplings while this deformation did not occur during the Ottawa River samplings. 
The hypothesis for this being that, for the Ottawa River samples, the devices were administered 
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using the projectile form and were therefore applied rapidly and hence more forcefully. This 
limited the potential for the force of insertion to be applied at a strange angle causing bending. For 
this reason, all future samplings of fish should be conducted using the projectile form of the SPME 
needle, as the rapid (more forceful, see equation 1) puncture of fish scales appears to provide a 
more uniform and repetitively successful sampler administration.  
 
Equation #1:  𝐹 =  𝑚𝑎, 𝑤ℎ𝑒𝑟𝑒, 𝑚 =  
𝑝
𝑣⁄  
 
Of significance however, is the demonstration that the SPME needle can be applied as a projectile 
through fish scales and into the underlying muscle tissue in on-site applications. Total time of 
sampler administration was measured on the order of single seconds using one hand, rather than 
the minute or so typically taken to introduce bio-SPME fibers using the syringe device, which 
requires two individuals for safe operation.65 
 Somewhat unfortunately, though good for the fish sampled, no target anthropogenic 
compounds were identified to be present in the samples from either site. This may be a result of 
the limited sampling time of 10 minutes and as a result longer sampling times should be applied 
in future applications. A 10 minute sampling time was employed rather than the typical 30 to 60 
minutes used in other SPME samplings of live fish, as the fish in this study were not anesthetized. 
In addition, once captured the fish were placed in a net which was hung from the side of the boat 
used, meaning that prolonged retainment of the captured fish could have been detrimental to the 
fish and logistically difficult given the circumstances.  
Screening of the resultant LC-HRMS data was conducted using XCMS online software, 
and more specifically its cloud-plot function. The cloud plots generated are based on box-plots 
F = force 
m = mass 
a = acceleration 
p = momentum 
v = velocity 
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formulated during the analysis process which compare average response and variation for each 
significant feature at each site. The m/z ratios identified as significant features were then input into 
online databases such as t3db.com, and metlin.scripps.edu.89,90 Though no pharmaceuticals or 
pesticides have yet to be tentatively identified to be present in the samples, data processing 
pertaining to significant features is still ongoing.  
 
4.4 Summary 
 
 Developed and presented in this chapter is an SPME device which is capable of directly 
puncturing fish scales or other protective tissue with no additional support or protection. Such a 
device facilitates the rapid administration of the SPME technology and will certainly see further 
application in a range of studies. The device was validated to be reproducible by the targeted 
analysis of pharmaceuticals spiked in water. It was also observed that the direct puncture of vial 
septa which are not pre-pierced resulted in the irreversible deposition of siloxane onto the coating 
surface under the experimental conditions used. The device was further applied to the targeted 
analysis of PUFAs in salmon tissue, and was compared to commercially available bio-SPME fibers 
where HLB-PAN SPME needles were found to provide the greatest sensitivity. Additionally, the 
process of puncturing protective fish tissue was validated to not affect the extraction of PUFAs 
from salmon. Finally, the device was incorporated into a projectile and applied to the analysis of 
wild muskellunge in an effort to identify anthropogenic compounds resulting from 
bioaccumulation. This study has yet to yield any positive result for these compounds, however 
further data analysis of this sample set is on-going. 
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5 Chapter 5: Summary 
 
 Two forms of the SPME technology have been applied to the targeted analysis of 
pharmaceuticals in environmental water. In the first case, a method was developed by which to 
apply the CBS technology to the rapid screening of WWTF effluent streams for target 
pharmaceuticals. Method LOD’s for all target compounds were confirmed to be less than 50 ng/L 
in river water, with LOQ’s for 75% of compounds being less than 100 ng/L. This methodology 
was then compared to a conventional SPE technique in a study of the final effluent streams of 6 
waste water treatment facilities where good agreement was observed. As a part of this study some 
limitations of the direct to MS technique of CBS were identified. It was observed that for the 
compounds propranolol and paroxetine there were multiple species in the sample solution which 
demonstrated the SRM transition monitored during the MS/MS detection and quantification of 
these species. This observation was validated by LC separation of the SPE extracts. Though these 
compounds are likely the metabolites of these target compounds, further work is certainly needed 
to resolve this issue for future applications of the technology for this purpose. For instance, ion 
mobility spectroscopy could be employed prior to MS/MS separation, or MSn could be employed 
in order to provide better compound resolution. 
 The second technology developed was that of the recessed SPME needle. With the 
realization of this technology, SPME sorbent phases can now be protected from the physical 
damage induced by puncturing protective tissue without the need of an additional protective 
housing or sheathing needle. The device was successfully applied to proof of concept studies 
extracting the PUFAs EPA, DHA, and ARA from salmon. In addition, the SPME needle was 
applied to the proof of concept on-site sampling of wild muskellunge where no mechanical damage 
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to the coating was observed and device deformation did not occur when administered as a 
projectile.  
 To conclude, the SPME technology has been advanced in two main ways. Firstly, with the 
comparison of CBS to SPE for the analysis of WWTF effluent, a rapid SPME method has now 
been confirmed as a viable method by which to perform the rapid screening of WWTF effluents 
for pharmaceuticals. In addition, with the introduction of recessed SPME coatings, rapid sampler 
introduction is now possible as protective housings and sheathing needles are not required, 
simplifying the device administration process.
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Appendix #1: Table of LC conditions and MS/MS parameters for analysis of 
pharmaceuticals  
 
LC separation conditions 
Time (min) 
Percent composition 
Flow (µL/min) 
A B 
0 10 90 300 
0.5 10 90 300 
10 100 0 300 
17.5 100 0 300 
17.9 10 90 300 
18.9 10 90 300 
 
LC-MS conditions CBS-MS conditions 
Spray voltage: 1300V 
Vaporizer temperature: 275°C 
Sheath gas: 30 
Auxiliary gas: 30 
Sweep gas: 2 
Capillary temperature: 275°C 
Q1 Resolution: 0.7 
Q2 Resolution: 0.7 
CID Gas (mTorr): 2 
Dwell Time (ms): 50 
Spray voltage: 4000V 
Vaporizer temperature:  
Sheath gas: 0 
Auxiliary gas: 0 
Sweep gas: 0 
Capillary temperature: 350°C 
Q1 Resolution: 0.7 
Q2 Resolution: 0.7 
CID Gas (mTorr): 2 
Dwell Time (ms): 50 
 
SRM parameters by compound 
Compound Parent (m/z) Daughter (m/z) Collision energy (eV) RF-Lens 
Diazepam 285.056 193.079 30 115 
Diazepam_d5 290.090 198.111 32 86 
Ranitidine 315.128 176.024 16 92 
Ranitidine_d6 321.183 130.040 25 49 
Codeine 300.134 152.059 60 120 
Codeine_d3 303.122 165.071 41 82 
Paroxetine 330.129 192.097 19 133 
Paroxetine_d6 336.157 198.111 21 71 
Fluoxetine 310.121 44.157 13 76 
Fluoxetine_d6 316.059 154.087 10 50 
Sertraline 306.057 158.955 29 75 
Sertraline_d3 309.03 158.929 31 106 
Salbutamol 240.147 148.071 16 79 
Propranolol 260.070 116.111 18 62 
Propranolol_d7 267.137 116.111 19 61 
Diazepam 284.995 193.054 32 82 
Diazepam_d5 290.090 198.111 32 86 
Methadone 310.048 265.007 15 57 
Methadone_d3 313.272 258.166 15 57 
Erythromycin 734.483 158.111 28 84 
Erythromycin_d6 740.483 164.111 28 82 
Monensin 694.391 676.419 35 187 
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Appendix #2: Target compound sensitivity dependence on sample pH 
 
 
 
 
 
0.00E+00
2.00E-04
4.00E-04
6.00E-04
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Carbamazepine
0.00E+00
1.00E-03
2.00E-03
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Propranolol
0.00E+00
5.00E-04
1.00E-03
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Diazepam
0.00E+00
5.00E-06
1.00E-05
5 6 7 8 9 10 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Methadone
0.00E+00
2.00E-04
4.00E-04
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Codiene
0.00E+00
2.00E-04
4.00E-04
6.00E-04
8.00E-04
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Ranitidine
0.00E+00
5.00E-04
1.00E-03
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Paroxetine
0.00E+00
1.00E-01
2.00E-01
5 6 7 8 9 10 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Erythromycin
0.00E+00
2.00E+03
4.00E+03
6.00E+03
8.00E+03
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Salbutamol
0.00E+00
5.00E+01
1.00E+02
1.50E+02
2.00E+02
5 7 9 11
C
al
ib
ra
ti
o
n
 S
lo
p
e
pH
Monensin
pKa = 15.9 
LogP = 2.8 
pKa = 9.4 
LogP = 3.5 
pKa = 3.4 
LogP = 2.8 pKa = 8.9 
LogP = 3.9 
pKa = 8.2 
LogP = 1.2 
pKa = 8.1 
LogP = 0.8 
pKa = 9.8 
LogP = 3.2 
pKa = 8.9 
LogP = 3.1 
pKa = 10.3 
LogP = 1.4 
pKa = 4.3 
LogP = 5.4 
79 
 
Appendix #3: Septa puncture damage induced to SPME needle coatings  
 
 
First instance of damage for each needle: 
 
 
 
 
 
 
 
 
 
 
 
Needle #2: After 50 punctures,     
        very minor damage 
        near tip 
Needle #1: After 35 punctures Needle #3: After 25 punctures 
